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SUMMARY
By 2020, two-thirds of the global burden of disease will be attributable to chronic
non-communicable diseases (e.g. cardiovascular disease and diabetes), most of them
strongly associated with diet. The pandemic of these diseases is likely, at least in part,
to be due to a mismatch between our current dietary patterns (i.e. excessive calories
and fat intake coupled with reduced dietary fiber intake) and those during man’s early
stages of evolution which our genes were programmed to respond to. However, the
interactions between our diet, genetic factors and the development of these diseases
are not fully understood.
Several microarray transcription profiling studies have examined the effects of a high-
fat, calorie-dense (HFC) diet but reported contradictory findings. One possible reason
for these discrepant findings may be due to the varying lengths of the feeding period.
We hypothesized that the HFC diet would initially elicit compensatory interrelated
responses between feeding behaviour and gene expression levels and that such
compensatory responses might diminish over time with the continued intake of a HFC
diet.
Therefore, we sequentially examined the effects of feeding a HFC diet to female
C57BL/6J mice. These included examining the feeding behaviour and the
transcriptomic profile of genes involved in the lipid metabolism in the liver and white
adipose tissue over a period of 10 weeks, making measurements at weeks 2, 4 and 10.
In parallel, we measured common phenotypic parameters associated with
cardiovascular diseases and obesity (e.g. plasma lipid, leptin and insulin levels).
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Our results suggested that the early responses to HFC feeding were possibly aimed at
reducing food intake, down-regulating the mRNA levels of lipogenic hepatic genes
and up-regulating the mRNA levels of genes involved in fatty acid oxidation.
However, prolonged HFC feeding appeared to disrupt this adaptation, leading to
increased food intake and marked increases in weight and body fat. Lipogenic genes
were also up-regulated. These effects were clearly dependent on the duration of HFC
feeding and became evident after 4 weeks. We have proposed a possible model
linking leptin signalling, hepatic lipid metabolism and the control of food intake
during the early and later stages of high-fat, calorie-dense feeding. Our sequential
observations may help to explain some of the discrepant findings in previous studies.
There are only a few studies examining the relationship between dietary fiber and
gene expression. These studies are limited to the gastrointestinal tract or only one or
two hepatic genes. Therefore, in a separate experiment, the thesis also examined
sequentially the effects of a high-fiber diet containing psyllium husk on the expression
levels of genes involved in lipid metabolism, using microarray technology. Whilst
plasma lipids were reduced by high-fiber feeding, mRNA levels of hepatic genes in
cholesterol synthesis were up-regulated throughout the feeding period and lipogenic
genes were also up-regulated with prolonged feeding.
Both experiments provided important molecular insights into the possible effects of
feeding a high-fat, calorie-dense diet or a high-fiber diet on genes involved in





HFC High fat, calorie-dense
FE Feed efficiency
EE Energy efficiency
PE High-fiber containing psyllium husk (PE)
qRT-PCR Quantitative real-time reverse-transcription polymerase
chain reaction
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“Let thy food be thy medicine and thy medicine be thy food.”
Hippocrates (460-377 B.C.)
The renowned Greek physician, Hippocrates, recognized that nutrition has an
important role in disease management. He had also observed that “Everything in
excess is opposed to nature.” Indeed, it is estimated that by 2020 two-thirds of the
global burden of disease will be attributable to chronic non-communicable diseases,
most of them strongly associated with diet (World Health Organization, 2003). The
transition from undernutrition towards overnutrition (i.e. a diet high in fat and calorie
content) plays a major role in the current global epidemics of cardiovascular disease,
diabetes and obesity.
Amongst the diet-related risk factors contributing to the development of these chronic
diseases, high blood cholesterol levels and being overweight are the second and third
most important risk factors respectively in developed countries and becoming
increasingly important in developing countries (World Health Organization, 2002).
The pandemic of cardiovascular disease, diabetes and obesity can be viewed as a
mismatch between our present environmental circumstances (e.g. an excessive calorie
and fat intake coupled with reduced physical activity) and those that give evolutionary
advantage. This concept was articulated by Neel (1962) in a paper entitled: Diabetes
2mellitus: a ‘thrifty’ genotype rendered detrimental by ‘progress’. Since then, this
concept has been widely accepted that our current dietary consumption patterns might
not be consistent with the diet to which our genes were programmed to respond.
However, the interaction between the diet and genetic factors and the effects that such
interplay might have on the development of these diseases is not fully understood
(Chiang and MacDougald, 2003; Mariman 2006). In the past, experimental designs
were often limited to one factor, i.e., either diet or genes were analyzed separately but
not simultaneously (Kaput, 2004). However, the completion of the sequenced human
(Venter et al., 2001; McPherson et al., 2001), mouse (Okazaki et al., 2002; Waterston
et al., 2002), and rat (Gibbs et al., 2004) genomes has brought forth a wealth of
information about the structure of the genome, which can now be used to study
concurrently the interplay between our genes and factors from the environment such
as diet.
There are 2 major approaches to study this interplay between diet
and genetic factors. One approach (nutrigenomics) aims to determine the influence of
diet on the genome activity and attempts to relate the resulting different phenotypes to
the differences in the genetic response of the biological system (Mutch et al., 2005;
Mariman, 2006). The other approach, nutrigenetics, aims to identify the genetic
variations in the population and how these gene variants may affect individual
response to the changes in the diet. The work of this thesis relied on the first approach
(nutrigenomics).
The research in this area is complicated by the fact that cardiovascular disease,
diabetes and obesity are polygenic in nature. Moreover, dietary intervention to
3prevent the onset of such diseases is a complex process that requires not only
knowledge of how a single nutrient may affect a biological system, but also how a
complex mixture of nutrients will interact to modulate biological functions. Therefore,
the thesis examined the effects of how a complex mixture of nutrients (i.e. the whole
diet) instead of a single-nutrient, would affect the gene expression as this reflects the
true dietary intake of humans. The transcription profiling is conducted using the DNA
array technology as this technology allows one to study thousands of genes
simultaneously. The choice of diet and the DNA array technology is discussed in
Chapter 2.
Whilst the consumption of a diet high in calories and fat content combined with
decreased energy expenditure associated with modern lifestyle, are the major
environmental causes of obesity and cardiovascular diseases (World Health
Organization, 2003), there is also evidence that a diet with increased dietary fiber may
reduce the risk of developing obesity and cardiovascular diseases (Kritchevsky and
Bonifeld, 1997). Background information on how a diet high in calories and fat
content and low in dietary fiber contributes to obesity and cardiovascular diseases is
discussed further in Chapter 2.
The C57BL/6J diet-induced obesity (DIO) mouse model is commonly used for studies
involving obesity, diabetes and cardiovascular diseases (Van Heek et al., 1997;
Ahren, 1999; Lin et al., 2000; Moraes et al., 2003). Further details on this mouse
model are discussed in Chapter 2. This mouse provides a good in vivo model to
investigate the relationship between dietary fat, energy intake and lipid homeostasis.
The liver and the adipose tissue play important roles in regulating energy stores and
4lipid homeostasis. A review of the current literature revealed that to date, the effects
of a typical high-fat, calorie-dense diet on gene expression levels in the liver and
adipose tissue in this mouse strain have been studied. These studies reported
discrepant findings in the gene expression levels (Table 1.1 and 1.2). Some showed an
increased expression of hepatic genes involved in lipogenesis (Hu et al., 2004;
Gregoire et al., 2002) whereas others showed a downward regulation by feeding a
high-fat diet (Kreeft et al., 2005; Kim et al., 2004). These studies were only carried
out at one single time-point or for a very short duration of feeding, i.e. 11 days
(Gregoire et al., 2002). In relation to gene profiling in adipose tissue, some found
increased expression of lipogenic genes (Li et al., 2002; Lopez et al., 2003) whereas
others demonstrated reduced expression of lipogenic genes in obese rodents (Nadler
et al., 2000; Soukas et al., 2000) and humans (Diraison et al., 2002). These previous
microarray approaches to examine the interplay between diet and genetic factors in
diet-induced obesity were performed solely on either liver tissue (Kreeft et al., 2005;
Kim et al., 2004) or on adipose tissue (Lopez et al., 2003; Moraes et al., 2003).
Furthermore, the various studies investigating the effects of a high-fat diet using
microarray profiling of the hepatic genes were conducted in the male mice only. Data
on the female mice have not been described previously.
We postulated that one of the reasons for the reported discrepant findings could be
due to the varying feeding duration, and that the ingestion of the high-fat, calorie
dense diet might elicit compensatory responses in the gene expression levels and
perhaps such compensatory response would diminish over time with the continued
intake of a high-fat, calorie dense diet.
5Literature on dietary fiber and gene expression is scant and usually limited to the
gastrointestinal tract ((Nguyen et al., 2006; Young et al., 2005; Chapkin et al., 1998)
or only on a few genes (Yang et al., 2003; Goel et al., 1999; Sonoyama et al., 1995).
To date, no studies have yet been carried out to examine the effects of dietary fiber on
hepatic gene expression on a large number of genes and in a time-dependent manner.
THESIS OBJECTIVES
It is postulated that the reason for the discrepant findings in the literature regarding
the findings on gene expression induced by a high-fat, calorie dense diet could be due
to the difference in duration of the feeding period and that the ingestion of the high-
fat, calorie dense diet might elicit compensatory responses in the gene expression
levels. We also proposed that this compensatory response would diminish over time
with the continued intake of a high-fat, calorie dense diet. Therefore, the thesis has the
following objectives:
1) To characterize sequentially the effects of a high-fat, calorie dense diet on the
transcriptomic profile of the genes involved in the lipid metabolism in the liver
and visceral white adipose tissue over a period of 10 weeks, making
measurements at weeks 2, 4 and 10.
2) To establish if there is any correlation between the transcriptomic profile of
the genes involved in the lipid metabolism and the common phenotypic
parameters associated with obesity and cardiovascular diseases (e.g. plasma
lipid profiles and plasma leptin).
63) In a separate experiment, the thesis also examined sequentially the effects of a
high-fiber diet containing viscous soluble fiber on the transcriptomic profile of
hepatic genes involved in the lipid metabolism, plasma lipids and body
weight.
THESIS ORGANIZATION
There are 6 chapters in this thesis. Chapter 1 provides a brief introduction,
background and rationale, defines the objectives and scope of the thesis. Chapter 2
reviews the literature on diet and gene expression studies as well as factors affecting
body weight regulation and lipid metabolism. The literature on the choice of mouse
model, diets and DNA arrays used are also discussed in Chapter 2. A detailed
description of materials and methods used is covered in Chapter 3. In Chapter 4, the
results from the high-fat, calorie-dense feeding experiment is reported. The discussion
of these results is found in the same chapter. Chapter 5 describes the findings from the
high-fiber experiment. Chapter 6 summarizes the important conclusions resulting
from this study and provides suggestions for future work.
7Table 1.1 Review of recent literature on dietary fat and hepatic gene expression






(16% of total energy as fat)
b) Severely high-fat diet
(not indicated in paper)
APOE3Leiden
mice
8 weeks Liver Reduced expression of lipogenic genes and
genes involved in cholesterol metabolism
Kim et al., 2004 a) Low-fat diet
(17% of total energy as fat)
b) High-fat diet
(36% of total energy as fat)
Male C57BL/6J
mice aged 3 week
12 weeks Liver Reduced expression of lipogenic genes and
genes involved in cholesterol metabolism
8Table 1.1 (continued) Review of recent literature on dietary fat and hepatic gene expression
Authors Diets used Animals used Duration
of diets
Tissue Results
Hu et al., 2004 a) Low-fat diet
(12% of total energy as fat)
b) High-fat diet
(40% of total energy as fat)
Male C57BL/6J
mice aged 6 week
8 weeks Liver Stearoyl-coenzyme A desaturase 1 (Scd1),




(17% of total energy as fat)
b) High-fat diet
(42% of total energy as fat)
Male C57BL/6J
mice aged 6 week
0, 1, 11
days
Liver Day 1 versus Day 0 :
Lipogenic genes were up-regulated but
returned to baseline at day 11
Day 11 versus Day 0 :
Genes involved in cholesterol metabolism
were down-regulated ; Pparα and Cpt1 were
up-regulated
9Table 1.2 Review of recent literature on dietary fat and adipose tissue gene expression














Reduced expression of lipogenic and
adipogenic genes in obese mice
Soukas et al.,
2000
No diets used (compared
between wild-type, ob/ob,
and transgenic mice







Reduced expression of lipogenic genes
and adipogenic genes in obese mice
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Table 1.2 (continued) Review of recent literature on dietary fat and adipose tissue gene expression
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Reduced expression of lipogenic genes
in obese subjects
Li et al., 2002 a) Control diet (4 % fat)








Increased expression of Stearoyl-
coenzyme A desaturase 1 (Scd1), a key
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b) High-fat diet











THE ROLE OF HIGH-FAT, CALORIE DENSE DIETS IN OBESITY
Obesity is a major health problem that is increasing in both prevalence and severity. It
is associated with increased risks of type 2 diabetes and cardiovascular disease.
Increased food intake, particularly a diet high in calories and fat content, combined
with decreased energy expenditure associated with modern lifestyle, are the major
environmental causes of obesity (Bjorntorp , 1997; World Health Organization,
2000). Numerous studies demonstrated that subjects given high-fat food also had a
high-calorie intake (Astrup et al., 2000; Golay and Bobbioni, 1997; Stubbs et al.,
1995). A diet excessive in dietary fat and calories promotes the development of
obesity. There is a direct relationship between the amount of dietary fat and calories
and the degree of obesity (Golay and Bobbioni, 1997). However, environmental
factors may not fully explain the rapidly increasing rates of obesity (Levin, 2000;
Moreno et al., 2001). Genetic predisposition for obesity may underlie the tendency for
weight gain in some individuals (Marti et al., 2000). To date, the interactions between
environmental and genetic factors and the effects that such interplay might have on
weight gain and maintenance is not fully understood (Chiang & MacDougald, 2003;
Mariman 2006).
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THE DIET-INDUCED OBESITY (DIO) MOUSE MODEL FOR DIET AND
GENE EXPRESSION STUDIES
The C57BL/6J diet-induced obesity (DIO) mouse model is commonly used for studies
involving obesity, leptin resistance, body fat accumulation, insulin resistance, and
correlation with body weight change (Van Heek et al., 1997; Ahren, 1999; Moraes et
al., 2003). Like humans, this strain would develop obesity, hyperglycemia and
hyperlipidemia when raised on a high-fat, calorie-dense diet. However, it remains lean
if the fat content of the diet is limited (Lin et al., 2000). Moreover, the development of
these risk factors in the C57BL/6J mouse closely parallels the progression in humans
(Collins et al., 2004). For example, the onset of diabetes and obesity in humans occurs
gradually and often in the presence of a high-fat, calorie dense diet (Collins et al.,
2004).
The current literature reporting the effects of a high-fat diet and microarray
transcription profiling of hepatic genes involved in lipid metabolism is limited to male
C57BL/6J mice. This is despite the fact that the female C57BL/6J mice were shown
to be more responsive towards high-fat diet than their male counterparts in terms of
gain in white adipose tissue mass over their total body mass. When fed with high-fat
diet for 8 weeks, the female mice characteristically exhibited 17.2% of their body
weight as adipose tissue mass as compared to 13.3% in the male mice
(http://phenome.jax.org). The females showed a 1.12-fold increase in their body
weights as compared to 0.98-fold change in the males. They also had a 5-fold increase
in total cholesterol levels as compared to a 4.8-fold increase in the males
(http://phenome.jax.org).
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LIPOGENESIS IN THE LIVER AND WHITE ADIPOSE TISSUE
To date, the mechanisms leading to the excessive body fat accumulation in obesity are
not fully understood. However, it is generally accepted that both decreased lipolysis
and increased lipogenesis could play a role in the pathogenesis of obesity. In the past,
the liver was considered to be the main site of lipogenesis while very little fatty acid
synthesis occurs in the adipose tissue. This view appears now to be incorrect as
significant lipogenesis is reported to occur in white adipose tissue (Aarsland et al.,
1996; Claycombe et al., 1998; Moustaid et al.,1996; Swierczynski et al., 2000).
The major adipose tissue in mammals is white adipose tissue (Albright and Stern,
1998). Adipose tissue in mammals is found in 2 different forms: white adipose tissue
and brown adipose tissue. Both white adipose tissue and brown adipose tissue play
opposing roles in regulating energy metabolism (Avram et al; 2005). One of the
primary roles of white adipose tissue is to store excess energy as fat whereas the
brown adipose tissue is responsible for transferring of energy from food into heat.
Increased white adipose tissue mass reflects a positive net balance in energy stores
between energy expenditure and energy intake (Avram et al; 2005). The classical
view of the function of white adipose tissue is that it purely provides a long-term fuel
reserve which can be mobilized during food deprivation with the release of fatty acids
for oxidation in other organs. A critical change in the perspective of the role of white
adipose tissue followed the discovery of leptin. (Zhang et al.,1994). This important
hormone for regulating energy balance is produced principally by white fat. In
addition to leptin, other cytokines have also been found to be produced by adipose
tissue. In fact, adipose tissue is no longer considered to be an inert tissue functioning
solely as an energy store, but is emerging as a major player in the pathogenesis of
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cardiovascular diseases, obesity, insulin resistance and related inflammatory disorders
(Tilg and Moschen, 2006).
Although both the liver and the adipose tissue play important roles in maintaining
energy balance and contributing to energy storage in the fed state, the previous
microarray approaches to examine the interplay between diet and genetic factors in
diet-induced obesity have frequently been performed solely on either liver tissue
(Kreeft et al., 2005; Kim et al., 2004) or on adipose tissue (Lopez et al., 2003; Moraes
et al., 2003) but not in both.
HIGH-FAT DIET AND GENE EXPRESSION STUDIES
A review of the current literature reveals that to date, the effects of a typical high-fat,
calorie dense diet on gene expression have been studied in vivo ( studies listed in
Table 1.1 and 1.2 found in Chapter 1). However, the diets used in some of these
studies are very high in fat content (Li et al., 2002; Lopez et al., 2003). These diets do
not reflect the typical fat content in a high-fat human diet, one of the important
environmental factors in causing obesity. Moreover, some of these studies used
genetically obese mice (Nadler et al., 2000; Soukas et al., 2000). These genetic
models may not be suitable models for examining human obesity as there are only
very few obese individuals reported in the literature with mutations of leptin or leptin
receptor. The current obesity pandemic results from a combination of both genetic
and environmental factors (e.g. a dietary intake excessive in calories and fat, coupled
with reduced physical activity).
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Studies which have examined the effects of a typical high-fat, calorie dense diet on
gene expression generated mixed findings. Some demonstrated that the expression of
hepatic genes involved in lipogenesis were up-regulated (Hu et al., 2004; Gregoire et
al., 2002) whereas others showed a downward regulation by feeding a high-fat diet
(Kreeft et al., 2005; Kim et al., 2004). These studies were either carried out at only a
single time-point or for a very short duration of feeding, i.e. 11 days (Gregoire et al.,
2002). In relation to gene profiling in adipose tissue, some observed increased mRNA
levels of lipogenic genes (Li et al., 2002; Lopez et al., 2003) whereas others found
reduced expression of lipogenic genes in obese rodents (Nadler et al., 2000; Soukas et
al., 2000) or humans (Diraison et al., 2002).
KEY GENES ENCODING SIGNIFICANT ENZYMES INVOLVED IN
LIPOGENESIS AND LIPID OXIDATION
Fatty acid synthase (Fas), a key-regulating enzyme in de novo lipogenesis, catalyzes
all the reactions for the conversion of acetyl-coenzyme A and malonyl-CoA to
palmitate (Wakil et al., 1983). Fas plays an important role in energy homeostasis by
converting excess food intake into lipids for storage and providing energy when
needed via oxidation. Fas transcription is under stringent nutritional as well as
hormonal control in lipogenic tissues, namely liver and adipose tissue (Wakil et al.,
1983; Hillgartner et al., 1995). For example, increased circulating insulin levels
induce Fas expression (Paulauskis and Sul, 1989). Experiments using knockout or
transgenic mice overexpressing sterol regulatory element-binding protein (Srebp)
demonstrated that this transcription factor plays a key role in the up-stream regulation
of Fas transcription (Casado et al., 1999; Shimano et al., 1999; Wang and Sul, 1995).
There are three Srebp isoforms. Srebp activates various genes involved in cholesterol
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and fatty acid biosynthesis. However, only the isoform, Srebf1 expression is induced
by feeding and insulin, and its role is mainly responsible for the regulation of fatty
acid synthesis (Horton et al., 2002).
On the other side of the equation of energy balance is energy production.
Mitochondrial beta-oxidation of long-chain fatty acids is a major source of energy
production. Carnitine palmitoyltransferase 1 (Cpt1) is the key regulatory enzyme of
hepatic long-chain fatty acid oxidation. Cpt1, an integral mitochondrial outer
membrane protein, catalyzes the transfer of long-chain acyl group of the acyl-CoA
ester to carnitine (McGarry and Brown, 1997; Ramsay et al., 2001). Cpt1 is tightly
regulated by its physiological inhibitor malonyl-CoA, the first intermediate in fatty
acid biosynthesis. This provides a mechanism for physiological regulation of beta-
oxidation in all mammalian tissues and for cellular fuel sensing based on the
availability of fatty acids (McGarry and Brown, 1997; Prentki and Corkey, 1996;
Zammit, 1999). By its strategic metabolic position, Cpt1 represents a potential drug
target for the treatment of metabolic disorders such as diabetes and coronary heart
disease. Much research has been devoted to this area (Ruderman et al., 1999; Unger
and Orci, 2001; McGarry 2002). Hyperglycemia with hyperinsulinemia increases
malonyl-CoA, inhibits functional Cpt1’s activity and shunts long-chain fatty acids
away from oxidation and toward fat storage in tissue (Rasmussen et al., 2002).
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BODY WEIGHT REGULATION AND FOOD INTAKE
Body weight regulation depends on the interaction between genetic and
environmental factors. The environmental factors that influence body weight
regulation ultimately act by a chronic modification of the energy balance equation
(Jequier, 2002):
Energy stored = Energy intake - Energy lost in faeces and urine - Energy expenditure
When studying body weight regulation, the critical issue is not the energy intake or
energy expenditure taken separately, but the adjustment of one to the other under ad
libitum food intake conditions (Flatt, 1997). The control of food intake exerts a
greater influence on energy balance than do small changes in metabolic rates that
occur during overfeeding or underfeeding. Under normal conditions, the variations in
food intake are larger as compared to the variations in energy expenditure, as shown
in subjects spending several days in a respiration chamber (Jequier and Schutz, 1983).
This suggests that food intake is the most important determinant of changes in energy
homeostasis. Impaired control of food intake has been shown to play a major role in
the etiology of obesity (Jequier, 2002). Studies on humans and animals which were
allowed ad libitum feeding on high-fat, calorie-dense diets demonstrated different
effects on food intake. Some showed that these subjects consumed similar amounts of
food as when they were fed ad libitum on lower-fat, less energy-dense diets
(Shepherd, 1988; Stubbs et al., 1995). Others, however, have shown that such HFC
diets inhibited food intake (Welch et al., 1988; Cecil et al., 1999) and yet others have
provided evidence that HFC diets promote hyperphagia (Warwick and Weingarten,
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1995; French et al., 1995; Lucas et al., 1998; Woods et al., 2003; Savastano and
Covasa, 2005).
DIETARY FATTY ACIDS AND PLASMA LIPIDS
In addition to increasing the risk of developing obesity, a high-fat diet particularly
high in saturated fats can also increase the risk of developing hyperlipidemia (World
Health Organisation, 2002).
Since the 1950s, it has been recognized that the fat content and the type of fat in the
diet is the major determinant of plasma cholesterol concentrations (Keys et al., 1950;
Hegsted et al., 1959). Saturated fatty acids1 increase total cholesterol; polyunsaturated
fatty acids decrease total cholesterol, and monounsaturated fatty acids have a neutral
effect (Keys et al., 1950; Hegsted et al., 1959; Clarke et al., 1997). The total
cholesterol-increasing effect of saturated fatty acids is almost twice the cholesterol-
decreasing effect of polyunsaturated fatty acids, resulting in dietary recommendations
that stressed reductions in dietary saturated fat (Lichtenstein, 2006). Not all saturated
fatty acids have identical effects on plasma cholesterol concentrations. Studies have
concluded that saturated fatty acids, particularly lauric (12:0), myristic (14:0), and
palmitic (16:0) acids, increase LDL cholesterol levels (Mensink et al., 2003; Yu et al.,
1995; Clarke et al., 1997). Shorter chain saturated fatty acids (6:0–10:0) have little
effect on plasma cholesterol concentrations, whereas those with intermediate chain
lengths (12:0–16:0) increase concentrations (Keys et al., 1965; McGandy et al., 1970).
It was suggested that the minimal effect of the shorter chain fatty acids could be due
1 In the nomenclature of fatty acids, the number before the colon denotes the number of carbon atoms
in the fatty acid hydrocarbon chain and the number after the colon denotes the .number of double
bonds. Saturated fatty acids do not contain any double bonds.
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to them being absorbed directly into the portal circulation (Bonanome and Grundy,
1988).
BODY WEIGHT REGULATION, PLASMA LEPTIN AND INSULIN LEVELS
Leptin is a hormone produced mainly by white adipose tissue. Its name is derived
from the Greek word ‘‘leptos’’ which means ‘‘thin’’. It is an important signal in the
regulation of adipose tissue mass and body weight. When energy reserves are
sufficient, leptin levels increase and this will reduce food intake. Conversely, when
energy reserves are low, leptin levels start falling and this will initiate a series of
neuroendocrine responses like stimulation of food intake to restore the energy
reserves (Ahima et al., 1996, Auwerx and Stacls, 1998). Therefore, it can be inferred
that leptin plays an important role in the regulation of body weight by adapting food
intake to current energy reserves. However, studies which have examined the rela-
tionship between circulating leptin levels and body weight regulation have generated
mixed findings. Studies found that mice which could not produce leptin or respond to
it, exhibited intense hyperphagia and developed massive weight gain (Campfield et
al.,1995; Pelleymounter et al., 1995). Treatment with leptin in the leptin-deficient
mice inhibited feeding and reduced body fat in a dose-dependent manner (Halaas et
al., 1995; Ahima et al., 1996). In humans studies, it was shown that individuals with
low plasma leptin levels were hyperphagic with aggressive behaviour when food was
denied and developed rapid weight gain, resulting in severe obesity (Montague et
al.,1997; Farooqi et al., 2002). In contrast to these studies, plasma leptin levels were
shown to be correlated positively with weight gain (Chessler et al., 1998) and body
mass index in humans (Niskanen et al., 1997; Klein et al., 1996; Caro et al., 1996). In
addition, it has been suggested that leptin synthesis is increased in obese subjects as
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compared to non-obese subjects (Maffei et al., 1995). As such, it was suggested that
leptin resistance rather than leptin deficiency could play a role in the pathogenesis of
obesity. In support of this hypothesis, leptin resistance was described in the diet-
induced obese C57BL/6J mice. Moreover, evidence indicated that these mice could
develop leptin resistance peripherally (Van Heek, 1997).
Tartaglia (1997) has demonstrated that leptin exerts its effects through activation of
the leptin receptor which belongs to the cytokine receptor superfamily and via
subsequent stimulation of the JAK/STAT pathway. These leptin receptors are found
in peripheral organs including liver and adipose tissue (Wang et al., 1997) as well as
the hypothalamus. The factors which determine leptin resistance include the
expression levels of leptin receptors as well as the responsiveness of intracellular
JAK/STAT signalling (Baskin et al., 1998). To date, the mechanisms by which
resistance to leptin may arise remain unclear. However, there was evidence to suggest
that Socs-3 (suppressors of the cytokine signalling family 3) may play a role. Socs-3
is a member of the Socs family of cytokine-inducible intracellular proteins that
feedback to inhibit cytokine receptors and cytoplasmic signalling adaptor molecules.
In vitro studies have demonstrated that Socs-3 inhibits leptin induced signal
transduction (Bjorbaek et al., 1998). This has led to the speculation that Socs-3
activation could play a role in the development of leptin resistance (Bjorbaek et al.,
1998; Emilsson et al., 1999).
Insulin is another hormone that also contributes to the regulation of body weight
(Porte et al. 1998). Studies have shown that insulin may inhibit food intake (Ikeda et
al. 1986, Forte et al. 1998), and stimulate energy expenditure by activating thermo-
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genesis in the brown adipose tissue (Rothwell et al. 1983). Therefore, insulin and
leptin seem to exert similar actions, the net effect being a reduction in body weight.
These effects seem also to be interrelated. However, insulin has been shown to
promote lipogenesis. Therefore, the net effect of insulin in the regulation of body
weight remains to be established.
DIETARY FIBER AND GENE EXPRESSION
Increased dietary fiber has been associated with reduced risks of developing
cardiovascular disease, colon cancer and obesity (Kritchevsky and Bonifield, 1997).
However, the literature on dietary fiber and gene expression is scant as compared to
the literature regarding dietary fat and gene expression. Studies are limited to the
gastrointestinal tract ((Nguyen et al., 2006; Young et al., 2005; Chapkin et al., 1998)
or only on one or two hepatic genes (Yang et al., 2003; Goel et al., 1999; Sonoyama
et al., 1995). To date, no studies have yet been carried out to examine the effects of
dietary fiber on hepatic gene expression on a large number of genes.
THE ROLE OF VISCOUS SOLUBLE FIBER IN LOWERING
CHOLESTEROL LEVELS
In relation to cardiovascular diseases, the health benefits of increased dietary fiber
intake in reducing the risk of cardiovascular diseases were first suggested over 30
years ago (Burkitt and Trowell, 1975). Since then, evidences of the link between
dietary fiber and cardiovascular diseases have accumulated from epidemiological
observations (Khaw and Barrett-Connor, 1987; Humble et al., 1993; Kromhout et al.,
1982; Rimm et al., 1996; Wolk et al., 1999) as well as clinical trials (Hjermann et al.,
1981; Arntzenius et al., 1985; Burr et al., 1989).
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Total dietary fiber can be divided into 2 groups: viscous soluble fiber and non-viscous
insoluble fiber. Non-viscous fibers have not been shown to have a consistent
cholesterol-lowering effect. In contrast, consumption of a high-fiber diet enriched
with viscous soluble fibers induced significant reductions in plasma total and LDL
cholesterol concentrations (Jenkins et al., 1978; Glore et al., 1994; Jenkins et al.,
2000). The cholesterol-lowering effects of viscous soluble dietary fiber could be due
to either (1) increased bile acid synthesis or (2) reduced cholesterol synthesis. Bile
acid synthesis accounts for 40-50% of the daily elimination of cholesterol (Heuman et
al., 1988; Vlahcevic et al., 1991) and plasma cholesterol is quantitatively the most
important substrate for bile acid synthesis (Schwartz et al., 1982). Endogenous
cholesterol biosynthesis accounts for approximately 75-80% of the total body
cholesterol pool (Schwartz et al., 1982). The liver is the main site of both bile acid
synthesis and endogenous cholesterol biosynthesis.
THE ROLE OF VISCOUS SOLUBLE FIBER IN ENERGY REGULATION
As compared to improved plasma lipid profiles, the evidence linking increased dietary
soluble fiber and weight loss faces substantial controversy since the number of
investigations reporting that soluble fiber induces weight loss (Tuomilehto et al.,
1980; Walsh et al., 1984; Krotkieswki, 1984) is comparable to the number reporting
no effect of soluble fiber on body weight (Hylander and Rossner, 1983; Stevens et al.,
1987; Krotkieswki, 1985). In part, this controversy stems from various factors which
include varying study duration as well as dietary compliance in human studies.
Studies which demonstrated the link between increased viscous soluble fiber intake
and weight loss have suggested that consumption of viscous soluble fiber result in gel
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formation in the stomach, which may increase gastric distension and reduce the rate of
gastric emptying. This gastric distension due to gel formation has been proposed as
the mechanism for the observed increases in perceived fullness and reduced food
intake following consumption of soluble fiber (Tuomilehto et al., 1980; Krotkieswki,
1984). The discrepant findings on soluble intake on weight could be due to varying
feeding period amongst other factors (e.g. non-dietary compliance) (Kritchevsky and
Bonifeld, 1997).
PSYLLIUM HUSK, A VISCOUS SOLUBLE FIBER
Of the viscous soluble fibers, psyllium husk appears to be the most effective (Bell et
al., 1990; Anderson et al., 1994) and with the least adverse side effects (Anderson et
al., 1990). Psyllium or ispaghula husk (the husk of the seeds of Plantago Ovata) is a
mixture of neutral and acid polysaccharides containing galacturonic acid. Some foods
in the human diet could potentially be enriched with psyllium husk, like breads,
breakfast cereals, pasta and snack foods. The effect of psyllium husk on fasting
plasma cholesterol has been evaluated in individuals with either
hypercholesterolaemia or obesity or diabetes (Frati-Munari, 1983; Bell et al., 1989).
In general, these studies show that psyllium husk cause a 5% reduction in total
cholesterol and 7-8% reduction in LDL-cholesterol and these reductions are sustained
in the long term (Anderson et al., 2000 a; Anderson et al., 2000 b). In relation to
obesity, the evidence linking psyllium husk supplementation and weight loss is far
less substantive. Nonetheless, a recent study has suggested a diet enriched with
psyllium husk could reduce the development of obesity by reducing adiponectin and
Tumor necrosis factor-alpha in obese Zucker rats (Galisteo et al., 2005).
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CHOICE OF MOUSE MODEL
In nutrigenomics, many different model systems are used, ranging from in vitro
cultured cells to animals and humans. The rationale for choosing the mouse model
over in vitro model is as follows. Firstly, the regulatory mechanisms involved in
responses to dietary perturbation are complex and organ-specific. Cell lines are
usually established through immortalization and cells in culture lack natural contact
with other cell types. Cultured cells, therefore, have lost part of their original tissue-
specific behaviour (Mariman, 2006). Secondly, cells are often very sensitive to
variation in the culture conditions. Usually, they can tolerate only the addition of one
or few components to the culture medium in a limited concentration. Hence, it will be
difficult to replicate the composition of a typical high-fat, calorie dense diet in the
culture medium as any changes could interfere with the activity and the effects of the
added components.
As for in vivo models, there would be many medical or ethical restrictions in taking
liver or white adipose tissue biopsies from humans. Therefore, the mouse model was
the next best choice among the various mammalian model systems for genetic
research because of its close genetic and physiological similarities to humans
(National Human Genome Research Institute website http://genome.gov/10005834).
Like humans, mice naturally develop obesity-related diseases that affect these
systems, including atherosclerosis, hypertension and diabetes. Moreover, the mice are
relatively inexpensive to maintain. Amongst the various strains of mice, the inbred
C57BL/6J mouse strain was chosen as it is commonly used as a model for human
obesity. This strain increases its weight, develops increased plasma cholesterol and
glucose levels when it is raised on a high-fat diet. The development of these risk
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factors in the C57BL/6J mouse closely parallels the progression in humans (Collins et
al., 2004). For example, the onset of cardiovascular disease, diabetes and obesity in
humans occur gradually and often in the presence of a high-fat, calorie dense diet
(Collins et al., 2004).
It has been shown that the female C57BL/6J mice are more responsive towards high-
fat diet than their male counterparts in terms of their gain in white adipose tissue mass
over their total body mass. When fed with high-fat-high calories diet for 8 weeks, the
female mice characteristically exhibit 17.2% of their body weight as adipose tissue as
compared to 13.3% in the males (http://phenome.jax.org). The females showed a
1.12-fold increase in their body weights as compared to 0.98-fold change in the males,
a 5-fold increase in total cholesterol levels as compared to a 4.8-fold increase in the
males (http://phenome.jax.org). There is limited literature describing diet-induced
obesity in the female C57BL/6J mice.
NUMBER OF MICE
Based on the guidelines from Cui and Churchill (2002), a minimum of 6 mice per
treatment group is needed in order to attain at least 80% power of detecting genes
with 1.5 fold change. This statistical power increases with more mice per treatment
group. As such, we had 8 mice in each group (for the high-fat, calorie dense
experiment) and 6 mice in each group (for the high-fiber experiment).
POOLING OF mRNA
Due to the high cost of the gene chips at the time of the experiment ($1500 per chip),
pooling was the only rational strategy. Moreover, mRNA samples are often pooled in
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a microarray experiment not just out of necessity (Jin et al., 2001; Saban et al., 2001)
but also in an effort to reduce the effects of biological variation (Chabas et al., 2001;
Waring et al., 2001; Agrawal et al., 2002). As pooling minimizes subject-to-subject
variation, it also enables easier detection of substantive features (Churchill and Oliver,
2001; Churchill, 2002; Kendziorski, et al., 2003; Allison, 2002; Han, et al., 2004).
Pooling is often desirable when primary interest is not on the individual (e.g., making
a prognosis or diagnosis), but rather on characteristics of the population (e.g.,
identifying biomarkers or expression patterns common across individuals) -- as in our
experiment design. In addition, Kendziorski et al. (2005) have recently studied the
effects of pooling in the context of microarray experiments and they found that
inference for most genes is not adversely affected by pooling. They recommended
that pooling should be done when fewer than three arrays were to be used in each
condition.
CHOICE OF DIET FOR THE HIGH-FAT, CALORIE DENSE DIET
EXPERIMENT
The high-fat, calorie dense (HFC) diet used in the study was formulated to mimic a
typical Western high-fat energy dense diet in humans (SF00-219, Specialty Feeds).
For humans, it is recommended that the intake of total fat and saturated fat should be
limited to less than 30% and 10% of daily energy intake respectively (World Health
Organisation, 2003). Amongst the saturated fatty acids, myristic and palmitic acids
have the greatest effects on raising total and LDL cholesterol levels.
The formula used in the HFC diet originated with researchers at Rockefeller
University and has been widely used to induce obesity in mice and rats. The HFC diet
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contained 21% fat (by weight), of which saturated fatty acids is the major component
(68%) of the total fatty acids. Both the fatty acids with intermediate chain lengths,
palmitic (16:0) acid and myristic (14:0) acid, comprised about 70% of the total
saturated fatty acids. Forty percent of the total calories in the HFC diet came from fat.
The saturated fat content of the HFC diet exceeded 10% of total calories. Hence, the
overall level of fat and the saturated nature of the fat are representative of diets that
are used to induce obesity and diets that are linked to risk of cardiovascular disease in
humans.
CHOICE OF DIET FOR THE HIGH-FIBER DIET EXPERIMENT
The formulation of the high-fiber diet used in the fiber feeding experiment was
modified from AIN-93M by supplementing it with 10% psyllium husk [Specialty
Feeds SF03-034, Specialty Feeds]. It consisted of 13.5% protein, 4% fat and 82.5%
carbohydrate, with a total fiber content of 15%. AIN-93M was formulated specifically
for maintenance of rats and mice (Reeves, 1997). The control diet for the high-fiber
feeding experiment contains 5g of fiber per 100g, whereas the high-fiber diet enriched
with psyllium husks contains 15g of fiber per 100g (i.e. 3 times more fiber). In
humans, the recommendation for fiber intake is to go up to 25g per day (i.e. about 3
times more fiber than the average current intake) (WHO 2003). Therefore, the
increase in fiber intake in the high-fiber group is approximately equivalent to the
recommended increase in humans.
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CHOICE OF ARRAYS FOR mRNA PROFILING
The three main technologies for examining gene expression are namely cDNA–AFLP
(cDNA–amplified-fragment-length polymorphism), SAGE (serial analysis of gene
expression) and the DNA microarray.
The cDNA–AFLP is a PCR-based method which starts with cDNA synthesis from
total RNA or mRNA using random hexamers as primers. The obtained fragments are
digested with two restriction enzymes and adapters are ligated to the ends of the
fragments. After linker ligation and limited PCR amplification with primers
complementary to the linker sequences, a second round of PCR amplification follows
with labelled primers mainly complementary to the 5’-end of the linker sequences.
These cDNA-derived restriction fragments are separated on polyacrylamide gels. The
differences in the intensity of the bands provide a measure of the relative differences
in the levels of gene expression. Individual genes can then be identified by cloning
and sequencing of the fragment. cDNA-AFLP can generate a global overview of gene
expression, but it involves a great amount of PCR reactions. In addition, separately
obtained data sets cannot readily be compared, which is in contrast to SAGE and
microarray data.
With SAGE, ‘tags’ – pieces of approximately 12 base pairs of cDNA - are first
generated. This length is sufficient to make each tag a unique representative of the
gene from which the corresponding mRNA was produced. The DNA molecules of
linked tags are then cloned and sequenced. The relative abundance of a particular tag
is a measure of the abundance of the corresponding mRNA in the original RNA
sample and as such it is a relative measure for the transcriptional activity of that
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particular gene. The limitations of this method include the requirement of a high-
throughput cloning and sequencing facility.
With the limitations of the above methods, the DNA microarrays have become the
preferred tool for mRNA profiling. Currently, the most common platforms are cDNA
microarrays and oligonucleotide microarrays.
A cDNA microarray comprises a collection of thousands of probes usually
corresponding to PCR products generated from cDNA libraries, expressed sequence
tag clones, or long genome cloned fragments, using either vector- or gene-specific
primers. The collection of probes is spotted onto a solid support either by mechanical
robotic microspotting or ink jet techniques. Though cDNAs have been the major
source of probes, over time researchers have discovered several disadvantages: high
clone set error rates arising from clone cross-contamination, mislabelling, missing
inserts, and phage contamination were persistent problems, particularly in large,
commercially available clone sets (Knight, 2001). Moreover, cross-hybridization
limited the specificity of the probes, i.e., a cDNA probe would detect the summed
expression of a number of gene paralogs (Miller et al, 2002). Therefore,
oligonucleotide arrays have become the preferred choice of many researchers. The
advantages of oligonucleotide probes are many and include greater specificity,
uniformity of hybridization, minimization of contamination, and improved quality
control measures. They also eliminate the need to verify and maintain vast collections
of cDNA clones and PCR products. Standing out among the oligonucleotide
microarray platforms are the high-density oligonucleotide Affymetrix Genechip
arrays synthesized in silico via photolithographic method. A silicon wafer is coated
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with synthetic linkers modified with photo-labile protecting groups. A
photolithographic mask is used to direct light to specific areas on the surface to
remove the protecting group. These unprotected deoxynucleosides are then available
to react with hydroxyl-protected deoxynucleosides that are incubated with the surface,
and chemical coupling occurs only at those areas that were previously illuminated. A
new mask is used to direct light to another specific set of physical location and the
steps are repeated until the oligonucleotide with the desired sequence and size
(typically 25 mer) is synthesized. To assess mRNA levels, each gene is represented by
a probe set of 11–25 oligonucleotide pairs (probe pair) covering the 3’ end of the
mRNA. A probe pair comprises one oligonucleotide that perfectly matches the gene
sequence (perfect match), and a mismatch oligonucleotide that carries a one-base
mismatch in the middle position of the sequence. The mismatch oligonucleotide is
used as control for nonspecific hybridization. The strategy of multiple probes per gene
compensates for cross-hybridization.
REAL-TIME REVERSE-TRANSCRIPTION POLYMERASE CHAIN
REACTION (RT-PCR)
RT-PCR (reverse-transcription polymerase chain reaction) is the most sensitive
technique for mRNA detection and quantitation currently available (Bustin, 2000).
Compared to the two other commonly used techniques for quantifying mRNA levels,
Northern blot analysis and RNase protection assay, RT-PCR can be used to quantify
mRNA levels from much smaller amounts of RNA (i.e. from as little as one cell). The
application of fluorescence techniques to the RT-PCR, with suitable instruments (e.g.
the Lightcycler, Roche), has led to widespread adoption of real-time RT-PCR as the
method of choice for validating results obtained from array analyses.
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Quantitative comparison of gene expression levels using real-time RT-PCR has the
advantages of speed and less chance of contamination as the entire process, starting at
the reverse transcription and ending with full quantification, is automated as
compared to the conventional RT-PCR. In addition, it does not require the laborious
procedures of running gel electrophoresis and quantifying band intensities. The
underlying concept in the quantification of gene expression with real-time PCR is the
measurement of the CT (Threshold Cycle). CT is always measured during the
exponential phase of amplification in a typical PCR reaction and is directly related to
the amount of target in the sample. The more template present at the beginning of the
reaction, the fewer number of cycles it takes to reach a point in which the fluorescent
signal is first recorded as statistically significant above background (Gibson et al.
1996). This point is defined as the CT.
Among the different fluorescence techniques, SYBR® Green (Molecular Probes) is
the most economical format for detecting and quantifying PCR products in real-time
reactions. SYBR Green is a dye that binds double-stranded DNA, and upon excitation
emits light. Thus, as a PCR product accumulates, fluorescence increases. The other
advantages of SYBR Green are that it is easy to use and it is sensitive. The
disadvantage is that SYBR Green will bind to any double-stranded DNA in the
reaction, including primer-dimers and other non-specific reaction products. This issue
of specificity and RT-PCR product verification can be addressed by conducting
melting curve analysis (Ririe et al. 1997) and gel electrophoresis to confirm the
amplified PCR products (Bustin, 2000). Melting curve analysis is conducted by
plotting fluorescence as a function of temperature to generate a melting curve of the
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PCR product. This is done by slowly increasing the temperature above the melting
temperature (Tm) of the PCR product and measuring the fluorescence. As the Tm of
the PCR product depends markedly on its nucleotide composition, it is possible to
identify the signal obtained from the correct product. A characteristic melting peak at
the melting temperature (Tm) of the PCR product will distinguish it from
amplification artefacts that melt at lower temperatures in broader peaks. Both melting






Female C57BL/6J mice, 8-week old, were supplied by the Laboratory Animal Centre,
National University of Singapore (NUS). They were acclimatized in our Animal
Holding Unit for 2 weeks, feeding on standard chow before starting on their
respective diets. They were kept in a room kept at 23 ± 1 0C with a 12-h light/dark
cycle (light period: 08:00h -20:00h). The mice were housed in polycarbonate cages
1x2x3 cm in size with wire lids, containing pelleted paper bedding [T.7984cs,
Teklad]. The mice were randomly divided into groups of 8 (for the high-fat, calorie-
dense feeding experiment) and groups of 6 (for the high-fiber feeding experiment).
Forty-eight mice were studied for the high-fat, calorie-dense feeding experiment and
twenty-four mice were used in the high-fiber feeding experiment. All animal
experiments were performed with the approval of the NUS Laboratory Animals
Centre.2
DIETS
For the high-fat, calorie dense (HFC) feeding experiment, the mice were fed ad
libitum with the control (C) diet or the high fat, calorie-dense (HFC) diet. The HFC
diet [SF00-219, Specialty Feeds] consisted of 21% fat (by weight). This diet provided
a total calorie content of 19.4 kJ/g. 40% of the total calories in the diet came from fat.
The C diet was standard chow diet [Rat and Mouse Cubes, Specialty Feeds] with
2 This was before the regulations of IACUC took effect.
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4.6% fat (by weight). The C diet provided a total calorie content of 14.3 kJ/g. Twelve
percent of the total calories in the diet came from fat.
For the high-fiber feeding study, the mice were fed ad libitum with either the control
diet (C) or the high-fiber diet containing psyllium husk (PE). The diet for the control
group was standard AIN-93M. The AIN-93M diet was formulated specifically for
maintenance of rats and mice (Reeves, 1997). It consisted of 13.5% protein, 4% fat
and 82.5% carbohydrate, with a total fiber content of 5% (by weight). The
formulation of the PE diet was modified from AIN-93M by supplementing it with
10% psyllium husk [Specialty Feeds SF03-034, Specialty Feeds]. It consisted of
13.5% protein, 4% fat and 82.5% carbohydrate, with a total fiber content of 15% (by
weight).
The ingredient listings and detailed nutrient composition of all diets used are listed in
Appendix 3.1. The amount of food intake was measured by subtracting the residual
food and food spillage from the total amount of food added weekly. Any food that
spilled was collected on white paper towels placed beneath the cages in which the
individual mouse was kept. After removing faeces and woodshavings from the paper
towels, food spillage was collected and weighed.
BODY WEIGHT MEASUREMENTS
Baseline body weight of the mice were obtained on a weighing machine (Shimadzu,
Libror EB- 20KH) when they first arrived. Subsequently, mice body weights were
measured weekly at the same time of the day using the same machine.
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MICE SACRIFICE AND TISSUE SAMPLES COLLECTION
At the end of the respective dietary treatments, the mice were sacrificed by cardiac
puncture after 12 hours of overnight fasting (20:00hr – 08:00hr). The mice were
anaesthetized by injection of CRC mixture (at 0.1ml/30g of body weight). The CRC
mixture contained ketamine and medetomidine. Blood was collected by cardiac
puncture technique as described in Appendix 3.2. The livers were harvested quickly
from the mice. Liver samples comprising the identical lobe were obtained from each
mouse. The liver samples were immediately snap-frozen in liquid nitrogen and stored
at -80°C. Intraperitoneal fat depots were rapidly removed, placed in pre-tared vials
and weighed. The fat tissue were then frozen in liquid nitrogen and stored at - 80°C.
LIPIDS AND GLUCOSE ASSAYS
Plasma total cholesterol, HDL cholesterol, triacylglycerol concentrations were
measured after an overnight fast using enzymatic assay kits on a Cobas Mira analyzer
(Roche). Before starting the respective diets, blood was collected from the tail of the
mouse as detailed in Appendix 3.3. LDL/VLDL cholesterol concentrations were
determined as the difference between total and HDL cholesterol concentrations. The
thesis would discuss LDL/VLDL cholesterol concentrations as LDL cholesterol
concentrations. Blood glucose levels were measured using the Accu-Chek glucometer
(Roche Diagnostic, Indianapolis, IN, USA) and Accu-Chek test strips (Roche
Diagnostic, 03603474) with appropriate calibration.
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GENE EXPRESSION PROFILING
Extraction of total RNA
Total RNA was isolated from frozen liver or from white adipose tissue from each
mouse using TRIzol® reagent (Invitrogen, 15596) according to the protocol listed in
Appendix 3.4. After isolation, the total RNA was purified using RNeasy® Mini Kit
(Qiagen, 74104) according to manufacturer’s instructions (Appendix 3.5). The
concentration and the purity of RNA were determined by UV spectrophotometry.
Absorbance of 1 OD read at 260nm in a 1cm light path is equivalent to 40ug/ml of
RNA. Pure RNA should have A260/A280 ratio of 1.9- 2.1 in 10mM Tris.CL, pH 7.5. A
2 ul sample was run on a 1% denaturing RNA gel to ensure that RNA was not
degraded after RNA extraction.
cDNA and cRNA synthesis
According to Affymetrix standard protocol (Appendix 3.6), cDNA was synthesized
from purified total and pooled RNA. Pure and undegraded total RNA was incubated
with 50 µM of T7-Oligo(dT) primer at 70 0C for 10 minutes, then cooled to 40C for 2
minutes. Superscript II reverse transcriptase was then added to the RNA-primer
mixture for the first strand cDNA synthesis. This reaction mixture was incubated for 1
hour at 42 0C and then cooled to 4 0C for 2 minutes. For the second strand cDNA
synthesis, dNTP, DNA ligase, DNA Polymerase 1 and RNase H were then added to
the first strand reaction mix and then incubated for 2 hours at 160C. Following reverse
transcription, 10ul of EDTA 0.5M was added to stop the reaction. Subsequently, the
double-stranded cDNA was transcribed in vitro to biotinylated cRNA by using the
Genechip IVT Labelling Kit (Affymetrix, 900182). The IVT Labelling reaction
mixture was incubated at 37 0C for 16 hours (overnight). All incubation steps were
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done in a PCR machine (Biometra®, T Personal). After performing the clean-up of
the biotinylated cRNA with GeneChip Sample Cleanup Module (Affymetrix,
900371), cRNA yield and concentration were determined by using the UV
spectrophotometer. A minimum concentration of 0.6µg/µl for the adjusted cRNA
yield was ensured before proceeding to the next step.
Hybridization and wash
Subsequently, the biotinylated cRNA was fragmented and mixed with control
oligonucleotide B2, 20X Eukaryotic Hybrization Controls (bioB, bioC, bioD, cre),
herring sperm DNA, BSA and the hybridization buffer. The hybridization cocktail
was heated to 99 0C for 5 minutes and then transferred to a 45 0C heat block for 5
minutes. After 5 minutes of centrifuging, the cocktail was injected into the probe
array cartridges. GeneChip® Mouse Genome 430 2.0 Array cartridges were used for
the high-fat, calorie dense diet experiment. GeneChip® Mouse Expression 430A
Array cartridges were used for the high-fiber feeding experiment. Gene expression
results for the two separate feeding experiments were analysed and discussed
separately. All probe sets represented on the GeneChip® Mouse Expression 430A
Array cartridges are included on the GeneChip® Mouse Genome 430 2.0 Array
cartridges. The 430 2.0 Array contains probes for about 34,000 known mouse genes
whereas the 430A Array only contains probes for about 14,000 known mouse genes.
In addition, the 430 2.0 Array cartridges also contain probe sets from the GeneChip
Mouse Expression 430B Array cartridges, which include probe sets against gene
clusters containing only EST sequences and some gene clusters with non-EST
sequences. Subsequently, these cartridges filled with the hybridization cocktail were
incubated at 45°C for 16 hours on a rotisserie at 60 rpm. The quality of the
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fragmented biotin-labelled cRNA in each experiment was checked before hybridizing
onto the Mouse Genome 430 2.0 and Mouse Expression Array 430A Arrays by using
Test-3 arrays. One of the major concerns in microarray experiments is generating full-
length labelled product. Incomplete product leads to a 3' bias, which can influence
data analysis. The Test-3 arrays contain characterized genes from all species and
provide a low-cost method of assessing sample quality before using the Expression
GeneChips. The quality of the biotin-labelled cRNA was examined by ensuring that
the signal ratio of the 3’/ 5’ probe sets should be no more than 3. After hybridization,
the arrays were washed in GeneChip Fluidics Station 400 and stained with
Streptavidin Phycoerythrin.
Microarray image and data analysis
Probe arrays were scanned on the Affymetrix GeneChip® Scanner 3000 after
washing. The GeneChip Operating Software Version 1.2.0.037 (Affymetrix) was used
to analyze the scanned image. For the experiment on the high-fat, calorie-dense diet,
expression patterns for each group were analysed according to the following pair-wise
comparisons. For instance, mice fed on high-fat, calorie-dense diet for 2 weeks (HFC-
2wk) were compared to mice fed on control diet for 2 weeks (C-2wk). Similar
comparisons were carried out for mice at weeks 4 and 10 (i.e. HFC-4wk versus C-
4wk and HFC-10wk versus C-10wk). For the experiment on high-fiber diet, the mice
fed on the high-fiber diet enriched with psyllium husk for 3 weeks (PE-3wk) were
compared to their corresponding controls (C-3wk). At week 10, the PE-10wk mice
were compared with the mice fed on the standard control AIN93M diet (C-10wk).
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The probe sets were sorted according to the following stringency criteria. In order to
get the robust “increase” expression profile, the experimental probe sets designated
“Absent” were eliminated and only the probe sets flagged as “I” with Signal Log
Ratio > 0.5 were selected. To obtain robust increase in the gene expression levels
between the treated versus the control groups, it is important to select transcripts that
are “Present” in the treated groups (i.e. high-fat, calorie-dense groups HFC or the
high-fiber groups). Hence, transcripts that are called “Absent” in the treated groups
are removed. On the other hand, when analyzing robust decrease in the gene
expression levels between the treated versus the control groups, “Absent” cells are
removed in the control groups and only those flagged “D” with Signal Log Ratio <
than -0.5 were selected. Data of “fold change” were calculated from the “Signal Log
Ratio”. Under in vivo conditions, changes in differential gene expression due to
dietary treatment are expected to be small and often below 2 fold change (Blanchard
et al., 2001; Barella et al., 2004). As such, any gene expression changes greater than a
threshold of 1.4 fold (i.e. signal log ratio of 0.5) were considered to be potentially
relevant. The selected probe sets were then annotated and classified using NetAffx
Gene Ontology (GO) Mining Tool. The gene expression data was presented using
TreeView (http://rana.lbl.gov/EisenSoftware.htm).
QUANTITATIVE REAL-TIME REVERSE-TRANSCRIPTION
POLYMERASE CHAIN REACTION (qRT-PCR)
qRT-PCR was conducted to validate our microarray results. Gene expression results
of 8 genes were selected. The primers sequences used are listed in Table 3.1. Absence
of genomic DNA contamination was confirmed by conducting control PCR reactions
containing RNA template, primers, and 2 μl of LightCycler DNA Master SYBR
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Green I (Roche, Diagnostics). This control PCR reaction did not contain reverse
transcriptase. The LightCycler RNA Master SYBR Green I one-step RT-PCR System
(Roche, Diagnostics) method was used to carry out cDNA synthesis and
amplification. Four hundred and fifty nanograms of total RNA obtained from each
mouse, primers, Mn(OAc)2 and LightCycler RNA Master SYBR Green I were mixed
well and transferred to LightCycler capillaries (Roche, Diagnostics). The cycling
conditions were set as follows: reverse transcription at 61 0C for 20 mins, followed by
initial denaturation at 95 0C for 30s. Subsequently, for 45 cycles, denaturation was
carried out at 95 0C for 5s, primer annealing step (conditions depend on primers),
extension at 72 0C for 1 min. Melting curve analysis was performed to assess the
specificity of the amplified PCR products. The amplified PCR products were
subjected to 2% agarose gel electrophoresis and visualized by UV fluorescence after
staining with ethidium bromide. Fold change in gene expression was calculated using
the delta threshold cycle (∆CT) method (Livak et al., 2001) and normalized against the
house-keeping gene -actin gene. The cycle number at which the reaction crossed an
arbitrarily placed threshold (CT) was determined for each gene, and the relative
amount of each gene mRNA to -actin mRNA was described using the equation 2-ΔCT
where ΔCT = (∆CT gene - ∆CT -actin ). In order to facilitate data presentation, relative
gene expression was multiplied by 104.
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Table 3.1 Sequences of primers used for RT-PCR
Gene name and
Gene symbol






























Tcctacgcttggggatgaaga tgaatcctattagcctccgatcac 126 bp
Leptin (Lep) cctgtggctttggtcctatctg ctgctcaaagccac cacctctg 416 bp
Leptin receptor
(Lepr)
tatgtcattgtacccataattatt cagagaagttagcactgtt 373 bp
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WESTERN BLOTS
Four mice from each group were randomly selected and individual liver samples
were used for the western blot assays. The liver tissues were homogenized in RIPA
buffer containing a mixture of protease inhibitors (Complete Mini EDTA-free, Roche
Applied Science). Denatured proteins (30 µg) were loaded onto polyacrylamide gels.
Following electrophoresis, proteins were transferred to nitrocellulose membranes
(Hybond ECL, Amersham) and stained with Ponceau S to confirm equal protein
loading. Membranes were then blocked with phosphate-buffered saline containing
0.1% Tween and 5% skimmed milk powder for 1 hr at room temperature and later
incubated overnight at 4°C with the respective antibodies: a rabbit antibody against 3-
hydroxy-3-methylglutaryl-coenzyme A reductase (Cell Signalling), fatty acid
synthase (BD Biosciences) and Cpt1L (Alpha Diagnostic International). Rabbit
antibody against -actin (Cell Signalling) was used for normalization. Subsequently,
membranes were incubated with a horseradish peroxidase-linked goat anti-rabbit IgG
(Cell Signalling) for 1 hr at room temperature. Following application of
chemiluminescent detection reagents (Amersham), Clear-Blue X-ray films (Pierce)
were exposed to the blots and the band intensities were determined using Quantity
One software (Bio-Rad).
PLASMA INSULIN LEVELS
Four mice from each group were randomly selected and their plasma insulin levels
were individually measured by a Rat/Mouse Insulin Elisa Kit (Linco Research,
EZRMI-13K). Monoclonal anti-rat insulin antibodies were pre-coated onto the wells
of the microtiter strips provided. Ten microlitres (ul) of samples, insulin standards of
concentrations ranging from 0.2 to 10 ng/ml and quality controls were pipetted into
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the wells followed by 80 µl of a biotinylated second polyclonal antibody. During the
first incubation, the insulin antigen bound simultaneously to the immobilized
(capture) antibody on one site and to the biotinylated antibody on the second site.
After removal of excess second antibody and washing, 100 ul of streptavidin-
horseradish peroxidase (enzyme) was added. This bound to the biotinylated antibody.
After a second incubation and washing to remove the unbound enzyme, a substrate
3,3’, 5,5’-tetramethylbenzidine solution was added, which was acted upon by the
bound enzyme to produce coloured product .The colour intensity of this product was
directly proportional to the concentration of insulin present in the original samples.
Each sample was done in duplicates. Absorbance was read at 450nm, corrected for
absorbency at 590 nm by a microplate reader.
PLASMA LEPTIN LEVELS
Four mice from each group were randomly selected and their plasma leptin levels
were individually measured by a Rat/Mouse Leptin Elisa Kit (Linco Research,
EZRML-82K). This assay is based on the binding of leptin in the samples by a pre-
titered antiserum. Ten microlitres of samples, leptin standards of concentrations
ranging from 0.2 to 30 ng/ml and quality controls were pipetted into the wells. After
incubating for 2 hours, and washing, 100ul of of biotinylated antibody was added.
After removal of excess antibody and washing, 100 ul of streptavidin-horseradish
peroxidase (enzyme) was added. After a second incubation and washing to remove
the unbound enzyme, a substrate 3,3’, 5,5’-tetramethylbenzidine solution was added.
Each sample was done in duplicates. Absorbance was read at 450nm, corrected for
absorbency at 590 nm by a microplate reader.
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STATISTICAL ANALYSIS
All results are expressed as means + SD. Statistical significance of differences was
analyzed by using Student’s t-test. Differences in measurements across the 3 time-
points were analyzed with 1-way ANOVA using Bonferroni post-hoc test. Pearson’s
coefficient of correlation (r) was used to determine the correlation between the
different variables. Spearman’s rank correlation coefficients were also calculated and
these tests gave identical results as Pearson’s coefficient of correlation (i.e. same
significance). As most of the data is normally distributed (e.g. body weight), the data
is presented with Pearson’s coefficient of correlation. The SPSS 14.0 package for
Windows (SPSS Inc., Chicago, IL) was used for statistical analysis. The significance
level was set at P < 0.05.
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CHAPTER 4
SEQUENTIAL EFFECTS OF A HIGH-FAT, CALORIE-DENSE DIET ON
FOOD INTAKE, BODY WEIGHT, PLASMA LIPIDS, LEPTIN, INSULIN AND
GENE EXPRESSION LEVELS
INTRODUCTION
The role of a high-fat, calorie-dense (HFC) diet as a major dietary risk factor
associated with obesity and cardiovascular disease has been outlined in Chapters 1
and 2. Several microarray transcription profiling studies have attempted to examine
the relationship between this dietary risk factor and the genetic responses. However,
the fat content in the diets used in some of these studies (Li et al., 2002; Lopez et al.,
2003) was very high. Therefore, these diets did not reflect the typical fat content in
the high-fat human diet. In addition, some studies have used genetically obese mice
(Nadler et al., 2000; Soukas et al., 2000). These genetic models may not be suitable
models for examining the influence of dietary risk factor on the development of
human obesity. In comparison, the diet-induced obese C57BL/6J mouse is a suitable
human obesity model. Further details on this mouse strain have been discussed in
Chapter 2.
We postulated that one of the reasons for the reported discrepant findings on high-fat,
calorie dense diet on food intake and on gene expression levels was due to the varying
lengths of feeding period (as reviewed in Chapter 2). We proposed that the ingestion
of a high-fat, calorie dense diet would initially elicit compensatory responses in food
intake and gene expression levels which would help to regulate energy homeostasis
and that such compensatory responses would diminish over time with continued
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excessive dietary intake of fat and calories. Obesity has been suggested as a
breakdown of the body’s ability to regulate energy homeostasis or to handle external
environmental perturbations e.g. a diet high in calories and fat (Kitano et al., 2004).
Since the body is always constantly adapting to the changes in a dynamic
environment, it would be interesting to examine how the body adapts to consumption
of a diet high in calories and fat over a period of time. Therefore, in parallel with the
microarray transcription profiling of the liver and the white adipose tissue, we
examined the changes in food intake, body weight, white adipose tissue mass, plasma
lipids, insulin, leptin and blood glucose levels over a period of 10 weeks.
The abbreviations used to name the groups are as follows: Mice fed on the high-fat,
calorie-dense (HFC) diet for 2 weeks (HFC-2wk), for 4 weeks (HFC-4wk) and for 10
weeks (HFC-10wk). The abbreviations for their respective controls are as follows: C-
2wk, C-4wk and C-10wk.
RESULTS
Feed consumption, energy and fat intake
Food intake was reported as the calculated average daily intake over the last 7 days
before the mice were sacrificed. It was shown in our preliminary study that daily food
intake was constant over this period when we measured food intake on eight mice
daily (Appendix 4.1). Energy intake was calculated from the energy density of the
diet multiplied by the amount of food consumed. Feed efficiency (FE) ratio was
calculated as the ratio of weight gained to the cumulative food intake over the same
period of the weight gained. Energy efficiency (EE) ratio was calculated as the ratio
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of weight gained to cumulative energy intake over the same period of the weight
gained.
During the first 2 weeks, there was no increase in the HFC mice’s food intake. In fact,
there was a slight decrease in HFC mice (3.06 ± 0.15 g/day) as compared to the
control mice (3.21 ± 0.09 g/day). This reduction in food intake was not significant.
However, at weeks 4 and 10, there were significant increases in the food intake of the
HFC groups when compared to their respective controls. The food intake in HFC-4wk
mice increased by 17% in comparison to C-4wk mice. At week 10, the high-fat mice
increased their food intake by 24% versus their controls (Figure 4.1). Energy intake
was significantly higher in all 3 HFC groups versus the controls (Figure 4.2). The
total fat content in the HFC diet was 4 times higher than the C diet. All the HFC mice
had significantly higher total fat (Figure 4.3) and saturated fat intake (Figure 4.4) as
compared to the C groups.
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Figure 4.1 Food intake of HFC and C mice
Results are presented as means ± SD for each group of mice (n = 8 / group) *: P <
0.05 compared to corresponding control group. Open bars represent data from C mice




















Figure 4.2 Energy intake of HFC and C mice
Results are presented as means ± SD for each group of mice (n = 8 / group) *: P <
0.05 compared to corresponding control group. Open bars represent data from C mice



























Figure 4.3 Total fat intake of HFC and C mice
Results are presented as means ± SD for each group of mice (n = 8 / group) *: P <
0.05 compared to corresponding control group. Open bars represent data from C mice



























Figure 4.4 Saturated fat intake of HFC and C mice
(A) Saturated fat intake among C mice
(B) Saturated fat intake among HFC mice
Results are presented as means ± SD for each group of mice (n = 8 / group).
All the HFC groups had significantly higher saturated fat content than the respective




















































Feed efficiency ratio and energy efficiency ratio
The feed efficiency (FE) ratio observed in the HFC-2wk mice was slightly lower than
the C-2wk mice. These differences did not attain a significant level (Table 4.1). There
was also a tendency for HFC-2wk mice to have lower energy efficiency (EE) ratio
than the C-2wk mice. At weeks 4 and 10, the FE ratios in the HFC mice were higher
than their controls (p < 0.01 at week 10) (Table 4.1). Higher EE ratios were also
observed for HFC-4wk and HFC-10wk mice when compared to their respective
controls. None of these differences in the EE ratios were significant (Table 4.1). The
EE ratios for the C mice were relatively stable across the 3 time-points. Both FE and
EE ratios increased over the whole HFC feeding period, with significant increase
between the HFC-2wk and HFC-10wk mice. The FE and EE ratios almost doubled for
HFC-10wk mice versus HFC-2wk mice (P < 0.05).
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Table 4.1 Feed efficiency (FE) ratio and Energy efficiency (EE) ratio of control and HFC mice
C: control diet groups HFC: high fat, calorie dense diet groups. Values are expressed as means + SD (n= 8/group)
** denotes P < 0.01 compared to corresponding C group
C-2wk HFC-2wk C-4wk HFC-4wk C-10wk HFC-10wk
FE ratio 14.96 ± 7.42 14.64 ± 10.12 15.04 ± 6.88 24.33 ± 11.42 15.69 ± 4.55 26.95 ± 7.01**
EE ratio 1.11 ± 0.55 0.75 ± 0.52 1.11 ± 0.51 1.25 ± 0.59 1.16 ± 0.34 1.39 ± 0.36
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Body weight
There were no significant differences in body weight amongst the groups at the start
of the feeding study (Table 4.2). Two weeks of high-fat, calorie-dense feeding did not
induce any significant weight gain (Table 4.2). Although an increase in weight gain in
the HFC-4wk mice (2.50 ± 1.14 g) as compared to the C-4wk mice (1.78 ± 1.13 g)
was observed at week 4, this difference was not statistically significant. It was only at
week 10 that we observed a significant large increase in weight gain in the HFC-10wk
mice (7.60 ± 1.89 g) as compared to the C-10wk mice (2.98 ± 1.98 g). When we
compared the amount of weight gained in relation to their initial body weights, we
observed that the percentage change in body weight was comparable between HFC-
2wk mice and C-2wk mice (Table 4.2). The HFC-4wk mice had an increase of 12.3%
over their initial body weights. This percentage increase in the HFC-4wk mice was
higher as compared to the percentage increase in C-4wk mice but this was not
statistically significant. The HFC-10wk mice had a 42.6% increase over their initial
body weights. This percentage increase was almost 2.7 times higher than the
percentage increase in the C-10wk mice (P < 0.01).
Between weeks 2 and 4, final body weight increased from 20.95 ± 0.75g in HFC-2wk
mice to 22.80 ±1.93g in HFC-4wk mice. Body weight increased to 26.0 ± 2.6g in
HFC-10wk mice (Figure 4.5). The difference between HFC-10wk mice and HFC-2wk
was significant (P < 0.01). Similarly, the increase between HFC-4wk mice and HFC-
10wk mice was significant (P < 0.01).
Based on the weekly weight monitoring of the HFC-10wk mice, we observed that
there was a slight reduction in HFC-10wk body weight as compared to C-10wk mice
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at week 1 (not significant) and the increase in body weight between the HFC-10wk
and the C-10 wk mice seemed to become more apparent after 4 weeks of high fat
feeding (Figure 4.6).
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Table 4.2 Initial body weight, gained body weight, percentage (%) change in body weight of control and HFC mice
C: control diet groups HFC: high fat, calorie-dense diet groups. Values are expressed as means + SD (n= 8/group)
** denotes P < 0.01 compared to corresponding C group
Initial body weight = Body weight at the start of feeding period
Gain in body weight = Final body weight – Initial body weight (e.g. Final body weight of C-4wk mice – Initial body weight of C-4wk
mice at the start of feeding period)
C-2wk HFC-2wk C-4wk HFC-4wk C-10wk HFC-10wk
Initial body weight (g) 19.91 ± 0.18 20.08 ± 0.14 19.86 ± 0.76 20.30 ± 1.15 19.28 ± 1.48 18.56 ± 1.95
Gain in body weight (g) 0.85 ± 0.59 0.88 ± 0.80 1.78 ± 1.13 2.50 ± 1.14 2.98 ± 1.98 7.60 ± 1.89 **
% change in body weight 4.31 ± 3.04 4.35 ± 4.03 9.05 ± 5.95 12.25 ± 5.23 16.39 ± 12.99 42.64 ± 10.12 **
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Figure 4.5 Final body weights of HFC and C mice over the 3 time-points
Results are presented as means ± SD for each group of mice (n = 8 / group). **
denotes P < 0.01 compared to corresponding C group. Triangles represent data from C
mice. Circles represent data from HFC mice.
Figure 4.6 Body weights of HFC-10wk and C-10wk mice at each week
Results are presented as means ± SD for each group of mice (n = 8 / group). **
denotes P < 0.01 as compared to corresponding C group. Triangles represent data
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White adipose tissue mass
Similar to the trend in body weight gain, there was no significant difference in white
adipose tissue mass in HFC-2wk mice (0.20 ± 0.05g) versus C-2wk mice (0.18 ±
0.01g) (Figure 4.7). However, significant deposition of white adipose tissue was
observed in HFC-4wk mice and HFC-10wk mice versus their corresponding controls
(0.34 ± 0.10 g versus 0.18 ± 0.05 g and 0.61 ±0.21 g versus 0.29 ± 0.06 g
respectively). The white adipose tissue mass in the HFC-10wk mice was nearly twice
the white adipose tissue mass in the C-10wk mice.
When we examined the relation between the white adipose tissue mass and the body
weight, we observed a significantly strong positive correlation between white adipose
tissue mass and the final body weight of all the mice ( r = 0.92, P < 0.01) (Figure 4.8).
About 85% of the variation in the white adipose tissue mass can be explained by the
final body weight of the mice. When we examined this relation separately in control
mice and HFC mice, we observed that the correlation between the white adipose
tissue mass and the final body weight was stronger in HFC mice ( r = 0.93, P < 0.01)
than in C mice ( r = 0.68, P < 0.01).
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Figure 4.7 White adipose tissue mass of HFC and C mice
Results are presented as means ± SD for each group of mice (n = 8 / group)
*: P < 0.05 compared to corresponding control group. Open bars represent data from

































Figure 4.8 Correlation between final body weight and white adipose tissue mass
Circles represent data from C mice. Triangles represent data from HFC mice.
(r = 0.92, P < 0.01)
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Plasma cholesterol levels
At the start of the feeding study, there were no significant differences in the total
cholesterol, LDL cholesterol, HDL cholesterol levels amongst the different groups.
Within 2 weeks of high-fat, calorie-dense feeding, total cholesterol levels were
significantly raised by 33% in the HFC-2wk mice as compared to the C-2wk mice
(2.22 + 0.39 mmol/L versus 1.67 + 0.09 mmol/L) (P<0.01) (Figure 4.9A). The HFC-
2wk mice also had a significantly higher LDL cholesterol levels as compared to the
C-2wk mice. Their LDL cholesterol levels were already 2.3 times higher than the
controls (0.60 + 0.15 mmol/L versus 0.26 + 0.12 mmol/L) (P < 0.05) (Figure 4.9B).
As the HFC feeding period continued, both the total and LDL cholesterol remained
significantly elevated in the HFC-fed mice as compared to the C mice. Unlike the
gains in body weight and white adipose tissue mass we observed in the mice, the
HFC-fed mice did not show a significant progressive increase in their total and LDL
cholesterol levels throughout the entire HFC feeding period. Total cholesterol levels
and LDL cholesterol levels in HFC-10wk mice increased by 16% and 37%
respectively when compared to HFC-2wk mice (non significant). There was no
significant progressive increase amongst the 3 HFC groups. Instead, we observed a
slight drop in total cholesterol levels in the HFC-10wk mice when compared to HFC-
4wk mice, although this difference was not statistically significant (Figure 4.9A).
HDL cholesterol levels were raised in all HFC groups but only the increase in HFC-
4wk mice was significant as compared with the C-4wk mice (Figure 4.9C). The
largest increase was also observed in HFC-4wk mice versus C-4wk mice. Their HDL
cholesterol levels increased by 45% from the levels observed in C-4wk mice (P <
0.01). Since high total cholesterol levels (which confer increased cardiovascular risks)
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are usually accompanied by high HDL cholesterol levels (which confer reduced
cardiovascular risks), we calculated the total/HDL cholesterol ratio to resolve this
dilemma. A higher total/HDL cholesterol ratio will confer greater cardiovascular
risks. The total cholesterol/HDL cholesterol ratios were raised in all the HFC-groups
as compared to the C groups but these increases did not reach statistical significance
(Figure 4.9D). The smallest increase in the ratio was observed in HFC-4wk mice (6%)
as compared to the C-4wk mice whereas the greatest increase in the ratio was
observed for the HFC-10wk (32%) mice compared to the C-10wk mice. These
differences in total/HDL cholesterol were not significant. The total/HDL ratio seemed
to increase with the HFC feeding period but did not reach significant differences
amongst the HFC groups.
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Figure 4.9 Plasma cholesterol levels of HFC and C mice
(A) Total cholesterol levels
C: control diet groups; HFC: high fat, calorie-dense diet groups. Values are expressed
as means + SD ( n= 8/group) ** denotes P < 0.01 when compared to corresponding C
group. Triangles represent data from C mice. Circles represent data from HFC mice.
Data at the week 0 (i.e. start of the feeding period) is calculated from the data from all































Figure 4.9 (continued) Plasma cholesterol levels of HFC and C mice
(B) Plasma LDL cholesterol levels
C: control diet groups; HFC: high fat, calorie-dense diet groups. Values are expressed
as means + SD ( n= 8/group); * denotes P < 0.05 and ** denotes P < 0.01 when
compared to corresponding C group. Triangles represent data from C mice. Circles
represent data from HFC mice. Data at the week 0 (i.e. start of the feeding period) is
































Figure 4.9 (continued) Plasma cholesterol levels of HFC and C mice
(C) Plasma HDL cholesterol levels
C: control diet groups; HFC: high fat, calorie-dense diet groups. Values are expressed
as means + SD (n= 8/group) ** denotes P < 0.01 when compared to corresponding C
group. Triangles represent data from C mice. Circles represent data from HFC mice.
Data at the week 0 (i.e. start of the feeding period) is calculated from the data from all

































Figure 4.9 (continued) Plasma cholesterol levels of HFC and C mice
(D) Total/HDL cholesterol ratio
Results are presented as means ± SD for each group of mice (n = 8 / group).




























At the start of the feeding study, there were no significant differences in the plasma
triglyceride levels amongst the different groups. We did not observe any significant
increases in the plasma triglyceride levels in the HFC mice until week 10. The plasma
triglyceride levels increased from 0.85 ± 0.03 mmol/L in C-10wk mice to 0.89 ± 0.02
mmol/L in HFC-10wk mice (Figure 4.10). The increased levels in HFC-2wk mice as
compared to the levels in C-2wk mice were not significant (0.91 ± 0.15 mmol/L
versus 0.80 ± 0.11 mmol/L). Plasma triglycerides levels appeared to be lower in the
HFC-4wk mice as compared to their controls (not significant).
Figure 4.10 Plasma triglyceride levels of HFC and C mice
C: control diet groups; HFC: high fat, calorie-dense diet groups. Values are expressed
as means + SD ( n= 8/group); * denotes P < 0.05 when compared to corresponding C
group. Triangles represent data from C mice. Circles represent data from HFC mice.
Data at the week 0 (i.e. start of the feeding period) is calculated from the data from all




























Plasma leptin levels were significantly raised within 2 weeks of HFC feeding (Figure
4.11). It increased from 1.35 ± 0.27ng/ml (C-2wk mice) to 5.03 ± 1.35ng/ml (HFC-
2wk mice). The levels in the HFC-fed mice continued to increase throughout the
entire feeding period, with significant increases in the HFC-4wk and HFC-10 wk
mice as compared to their corresponding controls (7.1 ± 2.38 ng/ml versus 1.57 ± 0.97
ng/ml; 18.44 ± 7.89 ng/ml versus 2.32 ± 1.32 ng/ml respectively). Between the 4th to
the 10th week of HFC feeding, we observed a sharp increase in plasma leptin levels by
159% (P < 0.01).
Figure 4.11 Plasma leptin levels of HFC and C mice
Results are presented as means ± SD for each group of mice (n = 8 / group) * denotes
P < 0.05 when compared to corresponding C group. Triangles represent data from C






























At week 2, there were no significant differences in the plasma insulin levels between
the HFC mice and their controls (i.e. 0.42 ± 0.07 ng/ml in the HFC-2wk mice versus
0.32 ± 0.06 ng/ml in the C-2wk mice) (Figure 4.12). At week 4, there appeared to be
an increase in plasma insulin levels in the HFC-4wk mice as compared to their
controls (0.81 ± 0.37 ng/ml versus 0.37 ± 0.07 ng/ml), but this increase did not reach
statistical significance. Subsequently, after 10 weeks of HFC feeding, we observed a
significant 3-times increase in the plasma insulin levels in the HFC-10wk mice (1.16
± 0.09 ng/ml) as compared to C-10wk (0.36 ± 0.06 ng/ml). There were significant
differences in the plasma insulin levels amongst the HFC-fed groups (P< 0.01). HFC-
10wk mice showed a 2.8-times and a 1.4-times increase as compared to HFC-2wk and
HFC-4wk mice respectively (P < 0.01 between weeks 2 and 10).
Figure 4.12 Plasma insulin levels of HFC and C mice
Results are presented as means ± SD for each group of mice (n = 8 / group) **
denotes P < 0.01 compared to corresponding C group. Triangles represent data from C





























Right up to 4 weeks of HFC feeding, there were no observable differences in blood
glucose levels between the HFC and C groups. Both the HFC groups at weeks 2 and 4
had comparable blood glucose levels as compared to their controls (Figure 4.13). It
was only at week 10 when we observed a significant sharp increase in blood glucose
levels in the HFC mice. Their glucose levels increased by 44% from 17.38 ± 3.6
mmol/ L (in the C-10wk mice) to 25 ± 3.65 mmol/L. During the initial HFC feeding
period, minimal increases were observed amongst the HFC mice. Mice fed on the
HFC diet for 4 weeks had blood glucose levels (17.38 ± 5.03 mmol/L) as compared to
mice fed on the HFC diet for 2 weeks (15.68 ± 3.63 mmol/ L). This increase was not
statistically significant. However, with prolonged HFC feeding, there was a sharp
increase in the HFC mice at week 10. The increase in the blood glucose levels
observed in the HFC-10wk mice was significantly different from the HFC-2wk
(increase by 59%, p < 0.01) and HFC-4wk mice (increase by 44%, p <0.01).
Figure 4.13 Blood glucose levels of HFC and C mice
Results are presented as means ± SD for each group of mice (n = 8 / group) **
denotes P < 0.01 compared to corresponding C group. Triangles represent data from C



























Correlation tests amongst plasma leptin, plasma insulin, white adipose tissue and
body weight in all mice
Plasma insulin correlated positively and significantly with plasma leptin (r = 0.81, P <
0.001) (Figure 4.14). When correlation analysis was conducted without the outlying
data-points, the correlation still remained strong and significant (r = 0.81, P < 0.01).
Hence, this demonstrated that the strong and positive correlation between plasma
insulin and plasma leptin was not driven by the outlying data point. All data-points
were included in the graph (Figure 4.14) . There were significant positive correlation
between plasma insulin, final body weight of the mice (r = 0.84, P < 0.01) (Figure
4.15) and amount of weight gained (r = 0.693, P < 0.001). There was a strong and
significant correlation between plasma insulin levels with white adipose tissue mass (r
= 0.92, P < 0.01) (Figure 4.16).
Plasma leptin also correlated significantly with final body weight of the mice (r =
0.86, P < 0.001) (Figure 4.17) and there was a strong correlation with white adipose
tissue mass (r = 0.93, P < 0.001) (Figure 4.18). However, it showed a weaker but
significant correlation with the amount of weight gained (r = 0.48, P < 0.05). The
relation between plasma insulin and plasma leptin lost significance after controlling
for body weight (r = 0.32, P = 0.13) or white adipose tissue (r = -0.28, P = 0.2).
Correlation tests amongst plasma leptin, plasma insulin and food intake in all
mice
At week 2, we observed a significant inverse relationship between plasma leptin
levels and food intake in the mice (i.e. as the plasma levels increased, the food intake
in the mice reduced) (r = -0.87, P < 0.05). This inverse relation between food intake
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and plasma leptin levels was not observed at week 4 and 10. There was also no
significant correlation between plasma leptin levels and food intake at these 2 weeks.
There was no significant correlation with plasma insulin and food intake till week 4
and week 10 (r = 0.89, P < 0.01, r = 0.93, P <0.01) respectively.
Correlation tests amongst plasma leptin, plasma insulin, white adipose tissue,
body weight and food intake in C mice
Plasma insulin correlated significantly with plasma leptin (r = 0.59, P < 0.05), final
body weight of the mice (r = 0.69, P < 0.05) and with white adipose tissue mass (r =
0.61, P < 0.05). Plasma insulin did not correlate with the amount of weight gained in
the C mice. Plasma leptin also correlated significantly with final body weight of the
mice (r = 0.86, P < 0.001), amount of weight gained (r = 0.69, p =0.01) and there was
a strong correlation with white adipose tissue mass (r = 0.93, P < 0.001). Plasma
insulin and plasma leptin did not correlate with each other after controlling for body
weight. Both leptin and insulin levels did not correlate with food intake respectively.
Correlation tests amongst plasma leptin, plasma insulin, white adipose tissue,
body weight and food intake in HFC mice
Plasma insulin correlated significantly with plasma leptin (r = 0.75, P < 0.01), final
body weight of the mice (r = 0.84, P < 0.001), amount of weight gained (r = 0.84, P <
0.001) and showed even a stronger correlation with white adipose tissue mass (r =
0.92, P < 0.001). Plasma leptin correlated significantly with final body weight of the
mice (r = 0.86, P < 0.001) but not with the amount of weight gained (r =0.46, P =
0.13). There was a strong correlation with white adipose tissue mass (r = 0.91, P <
0.001). Plasma insulin and plasma leptin did not correlate with each other after
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controlling for body weight (r = 0.09, P =0.79) or white adipose tissue (r = -0.52, P =
0.10). Only plasma insulin levels but not plasma leptin levels that correlated
significantly with food intake in the HFC mice (r = 0.93, P < 0.001).
Figure 4.14 Correlation between plasma insulin and plasma leptin levels
in both HFC and C mice
Circles represent data from C mice. Triangles represent data from HFC mice.
(r = 0.84, P < 0.01)
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Figure 4.15 Correlation between plasma insulin and body weight
in both HFC and C mice
Circles represent data from C mice. Triangles represent data from HFC mice.
(r = 0.80, P < 0.01)
Figure 4.16 Correlation between plasma insulin and white adipose tissue
mass in both HFC and C mice
Circles represent data from C mice. Triangles represent data from HFC mice.
(r = 0.85, P < 0.01)
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Figure 4.17 Correlation between plasma leptin and body weight in both HFC
and C mice
Circles represent data from C mice. Triangles represent data from HFC mice.
(r = 0.79, P < 0.01)
Figure 4.18 Correlation between plasma leptin and white adipose tissue mass
in both HFC and C mice
Circles represent data from C mice. Triangles represent data from HFC mice.
(r = 0.81, P < 0.01)
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Microarray profiling of hepatic genes involved in lipid metabolism over the
duration of high-fat, calorie dense (HFC) feeding
Under in vivo conditions, changes in differential gene expression due to dietary
treatment are expected to be small and often below 2 fold change (Blanchard et al.,
2001; Barella et al., 2004). As such, any gene expression changes from the microarray
screening greater than a threshold of Signal Log Ratio > 0.5 (i.e. 1.4-fold difference in
levels) were considered to be potentially relevant. The differential gene expression
levels were analysed according to the following pair-wise comparisons. For example,
hepatic gene expression levels in mice fed on high-fat, calorie-dense diet for 2 weeks
(HFC-2wk) were compared to the levels observed in the mice fed on control diet for 2
weeks (C-2wk). Similar comparisons were carried out for mice at weeks 4 and 10 (i.e.
HFC-4wk versus C-4wk and HFC-10wk versus C-10wk).
Hepatic genes involved in lipogenesis
Figure 4.19 shows the differential expression of the hepatic genes involved in lipid
metabolism. Genes encoding enzymes involved in lipogenesis, such as Acly, Acsm3,
Gpam, Mod1, Scd1 were down-regulated after 2 weeks of high-fat feeding (Figure
4.19A). At week 4, these genes were either up-regulated or showed no change. These
genes were up-regulated at week 10. Although the expression of genes such as Fas,
Srebf1, Dgat2, Fads1 and Fads2 showed no change at week 2, there was a trend of
being down-regulated. However, as the difference in absolute mRNA levels did not
reach statistical significance, they were not reported as a robust decrease. At week 4,
the main genes involved in synthesis of triacylglycerides (Fas and Srebf1) were up-
regulated and showed a further increase in mRNA expression at week 10. At week 10,
Acacb, Acsl5, Scd2, Acss2 Dgat2, Fads1 and Fads2 were also up-regulated.
75
Hepatic genes involved in fatty acid oxidation
At week 2, Cpt1L was up-regulated by 1.6 fold (Figure 4.19B). Other key genes
involved in fatty acid oxidation (FAO), Cpt1L, Pparα, Crat and Ehhadh were elevated
at week 4. This suggested that both mitochondrial and peroxisomal fat oxidation were
activated. At week 10, Pparα , Ehhadh, Hadhsc and Cpt2 were down-regulated and
Cpt1L and Crat were no longer up-regulated.
Hepatic genes involved in cholesterol metabolism
Analysis of the expression levels of the genes involved in the cholesterol synthesis
pathway revealed that the expression of key genes in this pathway, such as Hmgcs1,
Cyp51, Cyb5r3, Fdps, Idi1 and Sc4mol were decreased at week 2 (Figure 4.19C).
These genes continued to be suppressed and showed a greater suppression in their
expression levels at week 4. At week 4, additional genes involved in cholesterol
synthesis were down-regulated. These included Hmgcr, the gene which encodes the
enzyme catalyzing a rate-limiting step in cholesterol biosynthesis. Other genes were
Dhcr7, Dhcr24, Fdft1, Lss, Mvd, Mvk, Nsdhl, Pmvk, Sqle and Tm7sf2. Expression of
Srebf2, the transcription factor responsible for activation of the cholesterol synthesis
pathway, was also decreased. At week 10, the downward trend in the expression of
these genes was not maintained. Some genes were up-regulated instead (e.g. Hmgcr,
Sc4mol, Sc5d, Sqle, Cyb5r3, Fdft1 and Fdps).
Cyp7a1, the gene encoding the enzyme regulating the rate-limiting step of bile acid
synthesis were down-regulated at all 3 time-points.
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Figure 4.19 Hepatic genes involved in lipid metabolism regulated by high-fat,
calorie dense diet at weeks 2, 4 and 10.
The colour-coded scale (green=down-regulation and red=up-regulation). Data of “fold
change” were calculated from the “Signal Log Ratio”. The scale is presented as fold
change.
(A) Hepatic genes involved in lipogenesis
(B) Hepatic genes involved in fatty acid oxidation
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Figure 4.19 (continued) Hepatic genes involved in lipid metabolism regulated by
high-fat, calorie dense diet at weeks 2, 4 and 10..
(C) Hepatic genes involved in cholesterol metabolism
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Expression levels of hepatic genes involved in lipid metabolism measured by
quantitative RT-PCR
From the screening with microarrays, we selected one key gene each from lipogenesis
(Fas), fatty acid oxidation (Cpt1L), cholesterol metabolism (Hmgcr) and bile acid
synthesis (Cyp7a1) to conduct further qRT-PCR tests to validate their differential
expression (Figure 4.20). These genes were selected because they regulate the key
steps of fatty acid synthesis, fatty acid oxidation, cholesterol synthesis and bile acid
synthesis respectively. Melting curve analysis was performed to ensure the specificity
of the amplified PCR products. The individual melting curves are presented in
Appendix 4.2. The gel electrophoresis of the amplified PCR products are found in
Appendix 4.3.
HFC feeding resulted in a significant increase in gene expression of Cpt1L at week 2
and week 4 (p<0.05) (Figure 4.20). However, there was a downward trend at week 10
although this was not statistically significant.
At both weeks 2 and 4, there were no significant differences in the Fas mRNA levels
between the HFC and the C mice (Figure 4.20). At week 2, there appeared to be a
downward trend in the Fas mRNA levels in HFC mice but this was not significantly
different from the controls. At week 4, the downward trend observed at week 2
appeared to be reversed with increased levels of Fas mRNA levels in the HFC-4wk
mice as compared to the C-4wk mice (non-significant). At week 10, we observed a
57% significant increase (p<0.05) in the expression levels of Fas in the HFC mice as
compared to the C mice.
79
There were no significant changes in the Hmgcr expression levels between the HFC
and C mice at week 2 (Figure 4.20). HFC feeding for 4 weeks resulted in a highly
significant reduction in gene expression level of Hmgcr (p<0.01). This was reversed
at week 10. There was a significant increase in the expression levels of Hmgcr in the
HFC-10wk mice as compared to their controls (p<0.01).
The gene expression levels of Cyp7a1 were significantly down-regulated in the HFC
groups when compared to the C groups at weeks 2, 4 and 10. The levels were reduced
by 6.7 fold, 5.4 fold and 3.2 fold respectively (Figure 4.20). The qRT-PCR results
showed that the levels of mRNA for the selected genes followed the same pattern of
expression as those observed with the microarray experiment.
Correlation coefficient between microarray & qRT-PCR data
To validate the microarray date, qRT-PCR was carried out using individual mouse
samples. The qRT-PCR results were compared to the micorarray results (Figure 4.21).
The correlation coefficient was 0.93 (P < 0.01), confirming the reliablitiy of the
microarray data.
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Figure 4.20 Gene expression levels of Cpt1L, Fas, Hmgcr and Cyp7a1 measured by quantitative RT-PCR in liver tissues from HFC and































































































































































Figure 4.21 Correlation between microarray & qRT-PCR data (r = 0.93, p <
0.01.
Western blot analysis of Fas, Cpt1L and Hmgcr in the livers from C mice and
HFC mice
We subsequently verified the differential expression of Fas, Cpt1L and Hmgcr at the
protein level by western blot analysis (Figure 4.22). The individual gel electrophoresis
showing the various protein bands (run together with the protein markers) are found
in Appendix 4.5.
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There was no significant difference in the protein levels of Fas between the HFC and
C mice at week 2. At weeks 4 and 10, we observed significant increases in the protein
levels of Fas in the HFC versus their corresponding controls (Figure 4.22).
There was a significant increase in the protein expression of Cpt1L in the HFC-2wk
mice versus C-2wk mice. This significant increase in Cpt1L was also observed in
HFC-4wk mice versus their controls. At week 10, there appeared to be a downward
trend in the Cpt1L protein levels in HFC-10wk mice as compared to their controls but
this was not significant (Figure 4.22).
At weeks 2 and 4, there were significant reductions in Hmgcr protein expression
levels in HFC mice as compared to their controls. However, 10 weeks of HFC feeding
appeared to induce significant increase in the Hmgcr protein expression levels as
compared to the C mice (Figure 4.22).
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Figure 4.22 Top Panels : Western blot analysis of Fas, Cpt1L and Hmgcr in the livers from C mice (odd-numbered lanes) and
HFC mice (even-numbered lanes). 2, 4 and 10 weeks are arranged in rows (a), (b) and (c) respectively. Bottom Panels : Densitometry
analysis of protein bands normalized to -actin bands in C compared to the HFC mice. Each bar represents means ± SD for each
group of mice (n = 4/ group) *: P < 0.05 as compared to control group. Open bars represent data from C mice and filled bars represent
data from HFC mice.
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Microarray profiling of white adipose tissue genes involved in lipid metabolism
over the duration of high-fat, calorie dense (HFC) feeding
White adipose tissue genes involved in lipogenesis
In contrast to what we observed in the hepatic gene profile, we observed that the
genes encoding enzymes involved in lipogenesis were either down-regulated or
remained unchanged throughout the 10 weeks of HFC feeding (Figure 4.23A and
Figure 4.24). The gene encoding Acetyl-coenzyme A carboxylase, the rate-limiting
enzyme in fatty acid synthesis, was down-regulated within 2 weeks of HFC feeding. It
was further suppressed as the feeding period continued and its expression was down-
regulated by 2.6-fold by week 10. Other key genes which also play a pivotal role in
fatty acid synthesis (e.g. Acly and Acsm3) showed a progressive downward
regulation over the entire feeding period. At week 10, more genes involved in
lipogenesis were suppressed (e.g. Dgat1, Mod1, Pecr and Pcx). Although the
expression of key lipogenic genes such as Fas, Srebf1, Dgat2, Scd1, Gpam showed no
significant changes throughout, they had a tendency towards being down-regulated.
However, as the difference in absolute mRNA levels did not reach statistical
significance, they were not reported as a robust decrease.
White adipose tissue genes involved in fatty acid oxidation
Many of the genes involved in fatty acid oxidation (FAO) did not show any
significant changes in their expression throughout (Figure 4.23B). This included the
gene Lipe, encoding hormone-sensitive lipase, which catalyses the rate-limiting step
in adipose tissue lipolysis. Initially at week 2, Cpt1L and Cpt2 were up-regulated.
Cpt1L continued to be up-regulated at week 4. The expression levels of Cpt1L
increased by 2-fold in the HFC-2wk mice versus the levels in C-2wk mice. Both
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Cpt1L and Cpt2 were not differentially regulated at week 10. Acadm, Acox1, Crat,
Hadha and Pecr were all down-regulated at week 10.
Figure 4.23 White adipose tissue genes involved in lipid metabolism regulated by
high-fat, calorie dense diet at weeks 2, 4 and 10.
Data of “fold change” were calculated from the “Signal Log Ratio”. The scale is
presented as fold change.
(A) White adipose tissue genes involved in lipogenesis
(B) White adipose tissue genes involved in fatty acid oxidation
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Figure 4.24 Comparison of lipogenic genes expression levels in liver tissue versus white adipose tissue from microarray data





































































































































































White adipose tissue genes involved in leptin regulation
In agreement with the increased plasma leptin levels observed in the HFC-2wk mice,
we observed that the gene expression levels of Lep in white adipose tissue were up-
regulated by 2.3 fold (Figure 4.25). In contrast to the progressive increase in plasma
leptin levels, we observed that although all HFC-groups had higher expression levels
of Lep gene than their controls, the degree of up-regulation did not increase
progressively over the entire HFC feeding period. There was a tendency for Lepr to
be down-regulated at all time-points in the HFC groups but this was not reported as a
robust decrease. Socs3 was not differentially regulated till week 10 when it showed a
1.7-fold decrease in the HFC group. Stat3 was down-regulated at week 2 but not at
week 4. Subsequently, it was up-regulated at week 10.
Hepatic genes involved in leptin regulation
Lepr was not differentially regulated until week 10 when we observed a 2.2-fold
reduction in its expression in the HFC mice as compared to the C mice (Figure 4.25).
Socs3 was down-regulated by 3-fold and 1.4-fold in the HFC groups at both weeks 2
and 4 but this reduced expression was no longer observed at week 10.There was no
difference in the expression levels in Stat3 at all 3 time-points.
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Figure 4.25 Genes involved in leptin regulation in liver and white adipose tissue
regulated by high-fat, calorie dense diet at weeks 2, 4 and 10.
Data of “fold change” were calculated from the “Signal Log Ratio”. The scale is
presented as fold change.
Gene expression levels of Cpt1L, Fas, Lep and Lepr in white adipose tissue and
hepatic Lepr measured by quantitative RT-PCR
From the transcription profiling of the white adipose tissue with microarrays, we
selected one key gene each from lipogenesis (Fas), fatty acid oxidation (Cpt1L), leptin
synthesis (Lep) and leptin regulation (Lepr) to conduct further qRT-PCR tests to
validate their differential expression.
HFC feeding resulted in significant reduction in gene expression levels of Fas at all 3
time-points (Figure 4.26). At week 10, the reduction in the gene expression levels of
Fas in HFC-10wk mice versus the levels observed in the C-10wk mice was the largest
(47% reduction) as compared to the reductions in the other 2 time-points.
In relation to Cpt1L, we observed an up-wards trend in the HFC mice at weeks 2 and
4 (p < 0.01 at week 4). At week 10, there were no significant differences between
HFC and C mice (Figure 4.26).
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The Lep mRNA levels were significantly up-regulated in all the 3 HFC groups as
compared to C groups. Within 2 weeks of HFC feeding, the expression of Lep mRNA
levels went up by 7-fold (Figure 4.26).
There were no significant differences in the mRNA levels of Lepr in the HFC mice
versus the C mice at all 3 time-points (Figure 4.26).
We examined the Lepr mRNA levels in the mice livers. We found that the Lepr was
initially up-regulated in the HFC mice versus the C mice at both weeks 2 and 4 but
the increase was only significant at week 2. At week 10, this upwards trend reversed
and we observed a decreased expression of mRNA levels of hepatic Lepr in HFC-
10wk mice vs C-10wk mice (Figure 4.27).
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Figure 4.26 Gene expression levels of Cpt1L, Fas, Lep, Lepr measured by quantitative RT-PCR in white adipose
tissue from HFC and C mice.







































































































































































Figure 4.27 Gene expression levels of Lepr measured by quantitative RT-PCR in
liver tissue from HFC and C mice.


















































Correlation tests between expression levels of genes in white adipose tissue with
plasma leptin or plasma insulin levels
We examined the relation between the gene expression levels of Fas in white adipose
tissue and plasma leptin or plasma insulin levels. We found a strong and significant
inverse relation between mRNA levels of Fas in white adipose tissue and the plasma
leptin levels (r = -0.81, P < 0.001) of the mice at weeks 4 and 10 (Figure 4.28).
The minimum correlation coefficient, r that is significant for a sample size increases
with smaller sample size. In the example of Figure 4.28, r has to be at least -0.74 in
order to achieve significance at p = 0.001. If the number of mice were increased to 48,
the smallest r significant at p=0.001 is -0.46.
There was no significant relation between mRNA levels of Fas in white adipose tissue
and the plasma insulin levels (r = 0.08, P = 0.97).
Figure 4.28 Correlation between Fas mRNA levels in white adipose tissue
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r = - 0.88, P < 0.001
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Correlation tests between expression levels of hepatic genes with plasma leptin or
plasma insulin levels
We found a weak positive relation between mRNA levels of hepatic Fas and plasma
leptin levels (r = 0.52, P < 0.01). On the other hand, we found a strong, positive
correlation between the mRNA levels of hepatic Fas and plasma insulin levels (r =
0.70, P < 0.01) (Figure 4.29). We also found that the mRNA levels of hepatic Cpt1L
correlated positively and significantly with the plasma leptin levels (r = 0.80, P <
0.001) (Figure 4.30). For both Figures 4.29 and 4.30, when correlation analysis was
conducted without the outlying data-points, the correlation still remained positive and
and significant.
Figure 4.29 Correlation between hepatic Fas mRNA levels and plasma insulin
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Figure 4.30 Correlation between hepatic Cpt1L mRNA levels and plasma leptin
levels (r = 0.80, P < 0.001)
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Sequential effects of high-fat, calorie-dense (HFC) feeding on food intake, body
weight and white adipose tissue mass in the mice
At week 2, in an initial response to the high-fat, calorie dense feeding, it appeared that
the mice showed a slight reduction in their food intake. This could possibly help to
prevent weight gain and deposition of white adipose tissue mass in them. However,
this adjustment was not sustained. As the high-fat feeding period continued, there was
an increase in food intake associated with a marked increase in weight gain and
greater deposition of white adipose tissue. The increased food intake exhibited by the
HFC-4wk mice persisted in the HFC-10wk mice.
The changes in body weight and white adipose tissue mass were related to the
changes observed in food intake. There was no observable weight gain in the mice fed
on the HFC diet for 2 weeks versus their controls whereas the prolonged ingestion of
the HFC diet resulted in 1.4 and 2.5 times weight gain in the HFC-4wk and HFC-
10wk mice as compared to their respective controls. Similarly, it was only after 4
weeks of HFC feeding that we observed a significant deposition of white adipose
tissue mass in the mice.
Despite a lower food intake in the HFC-2wk mice, we expected an increase in the
weights of HFC-2wk mice as their calorie intake was significantly higher than the C-
2wk mice due to the higher energy density of the HFC diet. However, this was not the
case. In fact, there appeared a tendency for slight weight loss in all the HFC groups
after 1 week of HFC feeding as compared to their respective C groups. An example
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was shown in the weekly weight monitoring of HFC-10wk mice as shown in Figure
4.6. This weight loss was regained by week 2.
As the amount of food ingested was significantly different amongst the various
groups, we adjusted the weight gained for the amount of food intake consumed by
examining the feed efficiency ratio. We observed a reduction in the feed efficiency
ratio in the mice fed on the HFC diet for 2 weeks as compared to their controls (non-
significant). Ryu et al (2005) had shown that high-fat feeding for 12 weeks increased
feed efficiency ratio in rats. This discrepant finding between our observations at week
2 and the reported findings by Ryu et al (2005) could be due to the difference in
feeding length. Although the mice in our study fed on the HFC diet for 2 weeks did
not show an increase in their feed efficiency ratio, we found a similar trend in the feed
efficiency ratios in the prolonged HFC groups (i.e. HFC groups at week 4 and 10).
This trend was similar to what Ryu et al (2005) had observed. The feed efficiency
ratio of the HFC-10wk mice was significantly higher than their controls. The ratio
increased by 72% as compared to the control mice.
The higher energy density of the HFC diet as compared to the C diet might have
induced passive over-consumption of energy, which would lead to further weight
gain. Since the energy densities of the HFC and C diets differed, we examined the
energy efficiency ratios as well. Similar to the trend observed in feed efficiency ratios,
the mice fed on the HFC diet for 2 weeks appeared to have lower energy efficiency
ratios than their controls. At weeks 4 and 10, the energy efficiency ratios in the HFC
mice were higher than their respective controls (non-significant). The energy
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efficiency ratios increased progressively over the entire HFC feeding period, with a
significant almost 2-times increase for HFC-10wk mice versus the HFC-2wk mice.
In all, these observations in the feed efficiency and energy efficiency ratios suggested
that the propensity of the HFC diet to induce weight gain might be over and above the
effects of just passive over-consumption of energy from the higher calories in the
HFC diet. It was likely that the post-ingestive consequences of the HFC diet could
play a bigger role than the sensory properties (i.e. palatability or olfactory
characteristics) of a HFC diet in inducing increased food intake, resulting in further
weight gain. This seemed to agree with Warwick’s suggestion that a high-fat diet
having equal or even lower palatability or sensory properties than a low-fat diet can
still induce greater food intake (Warwick, 1996).
Therefore, our observations could support our postulation that the consumption of a
diet high in fat and calories did initially elicit compensatory feeding response but such
adaptations diminished with the continued intake of high-fat, calorie-dense diet ,
resulting in overeating and weight gain.
Moreover, our observations which demonstrated that HFC diets could also elicit
impaired control of food intake in normal (i.e. non-genetically modified) mice were
notable. Although the link between diminished control of food intake and chronic
excess of energy intake leading to the development of obesity seemed self-evident,
direct evidence for this relation only appeared in the late 1990s when studies reported
hyperphagia in humans with monogenic causes of severe obesity (Montague et al.,
1997; Farooqi et al., 2002) and in genetically-modified mice (Campfield et al.,1995;
Pelleymounter et al., 1995).
98
Sequential effects of high-fat, calorie-dense (HFC) feeding on hepatic gene
expression levels
Based on microarray experiments, we screened and found that the hepatic genes
involved in fatty acid oxidation were initially up-regulated and then subsequently
down-regulated during the course of HFC feeding. We selected and validated the
expression of Cpt1L, the rate-limiting enzyme for mitochondrial fatty acid oxidation,
with qRT-PCR. This enzyme catalyzes the formation of acyl-carnitine from acyl-
CoA. This reaction is the first step of the transport of long-chain fatty acids from the
cytosol into the mitochondrial matrix for fatty acid oxidation (McGarry and Foster,
1980). We found that the gene expression levels of Cpt1L were significantly up-
regulated at weeks 2 and 4. There was a trend of Cpt1L mRNA levels being down-
regulated at week 10. The initial increased expression levels of Cpt1L are also in
agreement with the findings by Gregoire and colleagues (2002). They had also shown
that Cpt1L were up-regulated in the livers of mice fed on high-fat diet for 11 days.
The differential changes in the gene expression were also translated to protein
expression as evidenced by our western blot assays.
In contrast to the genes in fatty acid oxidation, the microarray screening revealed that
several key hepatic lipogenic genes were initially down-regulated at week 2 but were
subsequently up-regulated at week 4 and more genes were up-regulated at week 10.
Several key hepatic lipogenic genes (e.g. Fas, Scd1, Acly) as well as the transcription
factor Srebf1 were up-regulated at week 10. Contrary to our observations in the group
of mice fed on the HFC diet for 10 weeks, Kim et al (2004) and Kreeft et al (2005)
showed that gene expression of lipogenic enzymes in their male C57BL/6J mice were
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down-regulated by high-fat feeding. They fed their mice on high-fat diets for 12
weeks and 8 weeks respectively. One possible reason for the discrepant findings
between our study and these 2 studies could be that dietary fat content of the high-fat
and control diets used in their studies was different from ours.
On the other hand, a more recent study conducted by Alevizos et al (2007) to profile
the transcriptional changes in C57/BL6 mice’s livers after feeding them high-fat diet
for 12 weeks also demonstrated that lipogenic genes, particularly Scd1, were elevated.
This was in line with our observations with the prolonged HFC groups. The fat
content of our HFC diet was similar to their high fat diet (i.e. about 40% of calories
from fat).
The difference in dietary fat content between the high-fat and control diets used in the
studies conducted by Murase et al (2001) and Hu et al (2004) was similar to ours. The
mice were fed high-fat diet for 8 weeks in the study conducted by Hu et al (2004).
Murase et al (2001) fed their male mice for a much longer period of time (i.e. 5
months). In agreement with our observations at week 10 (i.e. prolonged high-fat,
calorie-dense feeding), Murase et al. (2001) and Hu et al (2004) showed that the
C57BL/6J mice maintained on a high-fat diet had increased mRNA levels of hepatic
lipogenic genes. Within 4 weeks of the high-fat, calorie-dense feeding, we have
already observed increased mRNA levels of lipogenic genes. This might also be
observed by Murase et al. (2001) and Hu et al (2004) if they had conducted time-
course measurements.
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Although we did not carry out the sampling period beyond 10 weeks, we could
postulate that the increased levels of lipogenic genes would possibly remain elevated,
as inferred from the observations made by Murase et al (2001) and Alevizos et al
(2007).
We selected, validated and confirmed the gene expression of Fas, a key lipogenic
gene, by RT-PCR. In addition to its pivotal role in lipogenesis, there is evidence to
suggest that Fas controls feeding behaviour and, thus, may represent a therapeutic
target for the control of appetite and body weight (Loftus et al., 2000; Cha et al.,
2004; Kumar et al., 2002). We further examined the protein expression levels of Fas
in the mice livers. The trends in the gene expression levels of Fas were also translated
to the enzyme concentrations of Fas, as demonstrated in the western blot assays of
Fas. These experiments confirmed the increased concentrations of Fas in the HFC-fed
mice livers at weeks 4 and 10.
Could the sequential changes in hepatic gene expression involved in fatty acid
oxidation and lipogenesis possibly explain the changes in food intake?
In relation to these changes in food intake and weight gain in the mice, we examined
whether the molecular changes in the liver tissue could possibly help to explain some
of these sequential changes observed in the feeding behaviour. It has been suggested
that a stimulus generated at the level of fuel oxidation in the liver, provides a feedback
signal that links the oxidative metabolism of fuels to the control of food intake
(Friedman, 1990; Friedman and Tordoff, 1986; Langhans and Scharrer, 1987).
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Taken together, a possible interpretation of our above findings could be as follows. As
an initial response to high-fat feeding, the mice at week 2 showed a compensatory
response in an attempt to reduce their food intake through increased hepatic fatty
oxidation and reduced lipogenesis to regulate energy homeostasis. The possible
increase in hepatic fat oxidation might lead to an increase in hepatic energy, which in
turn, might send a signal to brain to reduce food intake (Friedman, 1998; Friedman et
al., 1999). The possible molecular mechanism for activating hepatic fatty acid
oxidation in the high-fat mice at week 2 is discussed in the later section in this
Chapter.
As the intake of high-fat feeding continued, we observed that hepatic lipogenesis
increased, which is known to result in an increased levels of malonyl-Co A (Wolfgang
and Lane, 2006). Malonyl-Co A, the first committed intermediate in the pathway of
fatty acid biosynthesis, is a potent Cpt1L inhibitor (McGarry et al., 1977; McGarry et
al., 1978). Hence, this could possibly inhibit hepatic fatty acid oxidation. In turn, this
could likely result in the removal of the stimulus to inhibit food intake and thus led to
increased food intake and weight gain observed in the mice fed the high-fat, calorie
dense diet at weeks 4 and 10. The initial attempt to regulate body weight gain in the
HFC-2wk mice could possibly explain the lower energy efficiency ratios of the HFC-
2wk group when compared to the C-2wk group. On the other hand, the other two
high-fat groups had higher energy efficiency ratios versus their corresponding
controls.
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Sequential effects of high-fat, calorie-dense feeding on plasma lipids in the mice
In agreement with the findings by Kreeft et al (2005) and Gregoire et al (2002), we
found that high-fat and a calorie-dense diet increased total and LDL cholesterol
levels. After 2 weeks of HFC feeding, there were significant increases in the levels of
total and LDL cholesterol, despite no significant changes in body weight in the HFC
mice as compared to their controls. The data from all the control mice were within the
normal range reported for female C57BL/6J mice (refer to Appendix 4.6 for
comparison).We had expected that the total and LDL cholesterol levels to show a
progressive increase over the HFC feeding period. However, total and LDL
cholesterol levels remained elevated with no significant progressive increases
amongst the HFC groups.
In line with the observations made by Gregoire et al (2001), we observed that HFC
feeding appeared to induce increased HDL cholesterol levels as well (significant only
at week 4) in the HFC mice. Since high total cholesterol levels (which confers
increased cardiovascular risks) are usually accompanied by high HDL cholesterol
levels (which confers reduced cardiovascular risks), we calculated the total/HDL
cholesterol ratio to resolve this dilemma. A higher total/HDL cholesterol ratio will
confer greater cardiovascular risks. We observed that this ratio was raised in all the
HFC groups as compared to the C groups (non-significant) and the ratio appeared to
increase with the HFC feeding period but there were no significant differences
amongst the HFC groups. At week 4, we observed that this increase in ratio in the
HFC versus the controls was the smallest as compared to the increases observed at
weeks 2 and 10.
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Another unexpected finding was the absence of significant increase in the plasma
triglycerides levels in the HFC mice at week 2. Subsequently at week 4, there
appeared to be a downward trend in the plasma triglyceride levels (non-significant).
These reductions in plasma triglyceride levels in the HFC fed mice were also
observed by Gregoire et al (2002) who fed their mice for 11 days. In contrast to these
observations made by us and Gregoire et al (2002), studies which examined the
effects of high-fat feeding for longer periods reported increased plasma triglyceride
levels (Kim et al., 2004; Milagro et al., 2006). At week 10, we also demonstrated that
the prolonged HFC feeding resulted in significantly higher plasma triglyceride levels.
These sequential observations on the plasma cholesterol and triglycerides levels over
the entire HFC feeding period would have been missed in single end-point feeding
studies. Taken together, our findings suggested that the mice might possibly develop
regulatory mechanisms to regulate their plasma lipid levels over the entire feeding
period, at least till week 4.
Could the sequential changes in hepatic gene expression involved in cholesterol
synthesis possibly explain the breakdown in cholesterol homeostasis?
This led us to further examine the expression levels of the hepatic genes involved in
cholesterol metabolism. As the majority of endogenous cholesterol synthesis in mice
occurs in the liver tissue, hence this thesis focused on examining the gene expression
levels related to cholesterol synthesis in the liver tissue only. Similar to the genes
involved in lipogenesis, the microarray screening showed that the genes involved in
cholesterol synthesis were also initially down-regulated. However, at week 4, more
genes involved in cholesterol synthesis were down-regulated as compared to week 2.
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This was in contrast to the genes involved in lipogenesis as it was at week 4 when we
started to observe an increased expression levels in the lipogenic genes. This seemed
to relate well with the observations that the cholesterol levels did not increase much
after 4 weeks of HFC feeding and there was no significant difference in the levels of
total and LDL cholesterols amongst the HFC groups over the entire feeding period.
Our findings could possibly suggest that the mechanisms in place to regulate
cholesterol levels in the mice could be more robust than the mechanisms to regulate
fatty acid synthesis. At week 10, we observed that this homeostasis regulatory
mechanism was breaking down with the increased expression of genes involved in
cholesterol synthesis (e.g. Hmgcr, Sc4mol, Sc5d, Sqle, Cyb5r3, Fdft1 and Fdps).
Our observations at both weeks 2 and 4 are in agreement with previous reports of
reduced expression of hepatic genes involved in cholesterol biosynthesis in mice fed
with high-fat diets (Kim et al., 2004; Kreeft et al., 2005; Gregoire et al., 2002). The
initial down-regulation of genes involved in cholesterol synthesis suggested that it
was unlikely that the increased cholesterol levels observed in the HFC mice at week 2
were due to increased hepatic cholesterol synthesis. Instead, one possible explanation
was that the liver was attempting to maintain cholesterol homeostasis in response to
high-fat feeding by down-regulating cholesterol synthesis. This is in line with
Goldstein and Brown’s suggestion that cholesterol homeostasis is maintained by a
feedback mechanism (Goldstein and Brown, 1990).
We could not compare our findings with Murase et al (2001) and Hu et al (2004) as
they did not investigate the expression of the genes involved in cholesterol synthesis.
As described in the earlier section about the similarities between our diets and theirs,
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we would expect that our upwards trend in gene expression at week 10 might have
been reported in their mice. To the best of our knowledge, this differential expression
of genes involved in cholesterol synthesis induced by HFC feeding has yet to be
reported. We further validated these gene expression changes by conducting western
blot assay for Hmgcr, which catalyses the rate-limiting step in cholesterol
biosynthesis. In agreement with the observations in the gene expression levels of
Hmgcr, we found that at weeks 2 and 4, there were significant reductions in Hmgcr
protein expression levels in HFC mice as compared to their controls. Prolonged HFC
feeding induced significant increase in the Hmgcr protein expression levels at week
10.
Since the expression levels of genes related to cholesterol synthesis were down-
regulated initially, this could not account for the increased plasma cholesterol levels
in the HFC-2wk mice. The other mechanism that might affect cholesterol levels
would be cholesterol removal. The diversion of cholesterol for bile acid production
has been well established as a mechanism for reducing plasma cholesterol (Fuchs,
2003). Interestingly, we observed that the gene expression of Cyp7A1, the enzyme
encoding the rate-limiting step of bile acid production, was consistently down-
regulated by high-fat feeding and Ldlr was down-regulated at week 4. We have
expected that the elevated plasma LDL levels would initially stimulate the Ldlr
expression to facilitate elevated lipid uptake from the periphery. This would then raise
liver cholesterol levels and accelerate bile acid production. We had also expected that
the gene expression of Cyp7A1 would be up-regulated as it governs the rate-limiting
step in the neutral pathway of bile acid synthesis from cholesterol. Therefore, our
findings suggested that for mice fed with HFC diet, it was not the up-regulation of
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cholesterol synthesis but rather the down-regulation of cholesterol removal
mechanism which resulted in the observed higher blood cholesterol levels. Based on
these observations, it is likely that the increased plasma cholesterol levels observed in
the HFC groups could be mainly due to the defect in cholesterol removal and bile acid
synthesis as the results suggested that the cholesterol synthesis was still well regulated
up to 4 weeks of high-fat feeding.
Sequential effects of high-fat, calorie-dense feeding on plasma leptin, insulin
levels in the mice
It has been proposed that both hormones, leptin and insulin, are involved in the
regulation of body weight and food intake. In agreement with studies conducted in
humans (Maffei et al., 1995) and in mice (Ahren, 1999), we observed that plasma
leptin levels correlated positively and significantly with body weight in all the mice (r
= 0.86, P < 0.001). Ahren also reported a strong and significant correlation between
plasma leptin levels and body weight (r = 0.81, P < 0.001). We found that the
correlation between plasma leptin levels with white adipose tissue mass was even
higher (r = 0.93, P < 0.001). Other studies of obese humans also showed a strong and
consistent positive relation between plasma leptin concentrations and adipose mass
(Maffei et al., 1995; Havel et al., 1996). Perhaps, plasma leptin, which is synthesized
mainly from white adipose tissue, could be proposed as a new measure of body fat in
addition to body mass index (BMI)3.
In line with findings reported by Ahren (1999) and Lin et al (2000), we demonstrated
that the plasma leptin levels were significantly up-regulated by HFC feeding at all
3 Body mass index is calculated as weight in kilograms (kg) divided by the height in meters (m)
squared (kg/m2). This index correlates with body fat.
107
time-points. In comparison with their studies which reported increased plasma leptin
levels in C57BL/6J female mice only after 4 weeks of high-fat feeding (Ahren 1999)
and 8 weeks of high-fat feeding (Lin et al., 2000), we had observed that 2 weeks of
high-fat, calorie dense feeding could induce a significant increase in the plasma leptin
levels. At week 2, the increase in plasma leptin levels in the HFC mice was 3.7 times
higher than the levels observed in the C mice. This observation was notable as the
significant increase in the plasma leptin levels had occurred despite no significant
increase in white adipose tissue mass in HFC-2wk mice as compared to C-2wk mice.
The plasma leptin levels in the C-2wk mice were within the normal range (i.e. 2.3 +
1.1 ng/ml) as described by Murphy et al (1997).
It has been demonstrated that the effect of leptin on energy homeostasis is to inhibit
food intake. Leptin-deficient ob/ob mice were hyperphagic, massively obese, severely
insulin resistant and diabetic, but this phenotype was reversed upon replacement of
leptin (Pelleymounter et.al., 1995). We investigated the correlation between plasma
leptin levels and the mice food intake. There was a significant inverse relationship
between the plasma leptin levels and food intake in the mice at week 2 but this inverse
relationship did not seem to occur at weeks 4 and 10. It appeared from our results that
there was no significant relation between plasma leptin and food intake with
prolonged HFC feeding.
Although the levels of plasma leptin remained significantly higher in the HFC-4wk
and HFC-10wk mice as compared to their controls, the inhibition on the food intake
was no longer observed. Instead these HFC mice exhibited hyperphagic feeding
behaviour and began to gain weight with greater body fat accumulation. The feed
108
efficiency and energy efficiency ratios also tend to increase in these HFC groups.
Since the leptin levels remained elevated at higher levels rather than at reduced levels,
this could likely suggest that it was due to the presence of leptin resistance rather than
reduced leptin production in the HFC-4wk and HFC-10wk groups that led to over-
feeding. This was also consistent with our observation that mRNA levels of leptin in
the white adipose tissue were significantly up-regulated in the HFC groups as
compared to the C groups at all 3 time-points. Moreover, the development of leptin
resistance in the HFC mice could also be inferred from the 2 previous studies by
Ahren (1999) and Lin et al (2000). Both studies demonstrated elevated plasma leptin
levels in mice fed with high-fat diets. Ahren (1999) showed that the mice continued to
have elevated plasma leptin levels up to 11 months of high-fat feeding. In a later
section in this Chapter, the possible link between hepatic lipid metabolism and leptin
resistance is discussed.
Is there a potential link between the changes in the plasma leptin levels,
differential hepatic gene expression involved in fatty acid oxidation and the food
intake in the HFC mice?
Back in the mid-1990s, Unger et al (1999) proposed a novel anti-lipogenic role for
leptin and they elegantly demonstrated how it could regulate lipid homeostasis by
stimulating fatty acid oxidation (FAO). In agreement with this postulation, we
observed an initial upward trend in the mRNA levels of hepatic genes involved in
fatty acid oxidation in our HFC-2wk mice which had increased plasma leptin levels.
Concurrently, these mice appeared to show a compensatory response to reduce their
food intake. In contrast to these observations, we observed increased food intake
accompanied by leptin resistance in the HFC mice fed for a longer period of time
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beyond 2 weeks. It was found that the hepatic genes involved in fatty acid oxidation
were no longer up-regulated in the HFC-4wk and HFC-10wk mice. A possible
interpretation of these observations could be as follows. As described earlier,
prolonged HFC feeding might lead to the development of leptin resistance in the
mice. In turn, this could reduce the stimulus on hepatic fatty acid oxidation. The
reduced hepatic fatty acid oxidation could subsequently diminish the feedback signal
sent to the central nervous system to regulate the food intake in the mice with
subsequent increased feeding observed in the HFC-4wk and HFC-10wk mice.
Could hepatic gene expression involved in lipid metabolism possibly be linked to
the development of leptin resistance in the HFC mice?
Leptin resistance is determined by the down-regulation of leptin receptor (Lepr) and
the up-activation of the suppressors of the cytokine signalling family 3 (Socs-3). In
Chapter 2, we have described these 2 factors which determine leptin resistance in
greater details. We examined the patterns of expression levels of the leptin receptor
and Socs-3 in the mice livers. We studied the possibility of suppressed hepatic Lepr
mRNA levels as well as up-regulated hepatic Socs-3 mRNA levels, which could
possibly help to explain the leptin resistance in HFC-4wk and HFC-10wk mice. In
agreement with this speculation, we found that Lepr was down-regulated by 2.2 fold
at week 10. Prolonged HFC feeding did not up-regulate the expression level of Socs-3
but we observed that the initial 3-fold decrease in Socs-3 mRNA levels at week 2 was
gradually removed over the entire feeding period. At week 4, it was only reduced by
1.4 fold and at week 10, Socs-3 was no longer down-regulated. These observations in
the mRNA levels of these hepatic genes over the various HFC feeding time-points
have not been previously described. Peiser et al (2000) reported that neither hepatic
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Lepr nor Socs3 mRNA levels were significantly regulated by 15 weeks of high-fat
feeding in rats. Nonetheless, they did demonstrate a non-significant reduction in the
mRNA levels of leptin receptor in the livers of the high-fat fed rats.
Therefore, our findings seemed to suggest that the higher circulating plasma leptin
levels in the HFC-4wk and HFC-10wk mice did not stimulate Socs-3 expression
levels. Rather, it could be the gradual removal of the inhibition Socs-3 in the HFC
mice fed that could result in leptin resistance in the HFC-4wk and HFC-10wk mice.
In turn, this leptin resistance could possibly account for the removal of stimulus on
the hepatic genes involved in fatty acid oxidation, resulting in a reduced signal to
reduce food intake. Subsequently, prolonged HFC feeding led to increased food
intake, weight gain and deposition of body fat in the HFC mice. This is discussed in
greater details in the later section “A possible model linking plasma leptin levels,
leptin signalling, hepatic lipid metabolism and food intake.”
Comparison of the transcription profiles between liver and white adipose tissue
When we examined the expression profiles of lipogenic genes in the liver tissue and
the white adipose tissue over the entire HFC period, we found that the lipogenesis was
initially suppressed in the liver tissue and subsequently it was up-regulated by 4
weeks of HFC feeding. On the other hand, we observed that the lipogenic genes were
not up-regulated but were either suppressed or remained unchanged throughout the 10
weeks in white adipose tissue. In addition, the mRNA levels of Srebf1 in the white
adipose tissue, a main transcription factor that controls the expression of the lipogenic
pathway, were also not up-regulated throughout the feeding period. We found that
there was a greater degree of down-regulation of lipogenic genes with longer period
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of HFC feeding. This contrasted with our expectations. We have expected to find
evidence to suggest enhanced lipogenesis in white adipose tissue which may
contribute to the development of the excessive fat mass in the HFC-10wk mice.
Nonetheless, this reduced or normal lipogenic gene expression levels in the HFC mice
agree with previous reports that have examined the expression of lipogenic genes in
adipose tissue from obese humans (Diraison et al., 2002) and ob/ob mice (Nadler et
al., 2000; Soukas et al., 2000). Based on their findings, the authors reasonably
suggested that the reduction of gene expression levels in the white adipose tissue mass
could be a late and adaptive process aimed at limiting or preventing further
development of fat mass. However, our findings over the various time-points showed
clearly that this was not likely to be the case.
The discordant finding between the transcription profile of the lipogenic genes in the
liver and that of the adipose tissue was interesting as the basic mechanisms
responsible for the regulation of the expression of the lipogenic pathway are
considered to be similar in hepatocytes and adipocytes (Ferre, 1999; Girard et al,
1994). It is possible that the raised leptin levels of the HFC mice could partially
explain the discrepant observations. There is data supporting a suppressive action of
leptin on the transcription of Fas (Bai et al., 1996) and Srebf1 (Soukas et al, 2000) and
on in vivo lipogenesis (Bryson et al, 1999; Lee et al., 2000). Although this action is
present in both liver and adipose tissues, a direct, paracrine effect in adipose tissue
could explain a more marked action on adipocytes in vivo. Indeed, we observed a
strong and significant inverse relation between mRNA levels of Fas in white adipose
tissue and the plasma leptin levels (r = -0.88, P < 0.001) of the mice at weeks 4 and
10, but not at week 2. The subsequent increased gene expression levels of hepatic Fas
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in the HFC-4wk and HFC-10wk mice could reflect the decreased leptin sensitivity in
the livers with the prolonged HFC feeding as described earlier.
The raised insulin levels observed with extended HFC feeding could also possibly
explain the enhanced levels of expression of hepatic genes involved in lipogenesis. It
has been shown that insulin stimulated the transcription of lipogenic genes in rat
hepatocytes and adipocytes (Claycombe et al., 1998). An increase in plasma glucose
stimulates insulin release. We observed significant increases in both the glucose levels
as well as the plasma insulin levels in HFC-10wk mice when compared to their
controls. We also observed that the plasma insulin levels correlated positively with
the mRNA levels of hepatic Fas (r = 0.74, P < 0.01). In contrast, there was no
significant relation between the mRNA levels of Fas in adipose tissue with the plasma
insulin levels. This could possibly indicate a stronger influence on the regulation of
lipogenic genes in the liver tissue as compared to the white adipose tissue by insulin.
However, the exact mechanisms would have to be verified by further investigations.
Taken together, the varying levels of plasma insulin and leptin as over the 3 time-
points in our study could play a role in the in vivo difference we observed between
liver and adipose tissue lipogenic gene expression levels in the HFC mice.
A possible model linking plasma leptin levels, leptin signalling, hepatic lipid
metabolism and food intake
Initial compensatory responses to high-fat, calorie-dense feeding
A possible model to explain our sequential findings could be as follows (Figure 4.31).
During the initial period of high-fat, calorie-dense feeding, the mice might have
developed compensatory mechanisms to reduce their food intake by increasing leptin
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synthesis in the white adipose tissue. In support of this, we found increased mRNA
levels of leptin in the white adipose tissue as well as increased plasma leptin levels in
the mice fed on the high-fat calorie-dense diet for 2 weeks as compared to their
controls.
Plasma leptin exerted its effects through activation of the leptin receptor which could
be found in the hypothalamus as well as peripheral tissue (e.g. the liver). Besides
sending neuroendocrine signals to the brain to inhibit food intake, the increased
circulating plasma leptin might possibly exhibit its inhibition on food intake via its
influence on the balance of lipid homeostasis in the liver. The elevated levels of
plasma leptin might possibly inhibit food intake by increasing hepatic fatty acid
oxidation. This stimulation of hepatic fatty acid oxidation is likely to occur via leptin-
stimulation on the JAK/STAT signalling pathway. Our microarray results also
showed that several genes involved in JAK/STAT signalling pathway (for example
Cxcl9, Ccnd1, Egfr, Il2rg, Junb, Pias1, Pim1, Ptprc, Smad4, Socs2 and Sp1) were all
initially up-regulated and either showed a downward trend or no change with
prolonged high-fat feeding. The possible leptin-mediated stimulus on hepatic fatty
acid oxidation via JAK/STAT signaling pathway could be inferred from studies
conducted by Tartaglia (1997) and Roger et al (1999). Tartaglia provided evidence
that leptin exerts its effects through activation of the leptin receptor and via
subsequent stimulation of the JAK/STAT pathway (Tartaglia, 1997). Roger Unger
and his colleagues showed convincing evidence that leptin, via stimulation of the
JAK/STAT pathway, could stimulate fatty acid oxidation (Unger et al., 1999). In turn,
the increased hepatic fatty acid oxidation might send nerve impulses to the brain by
vagal sensory neurons to reduce food intake in the mice. Early work by Friedman et al
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(1998; 1999) supported this concept. More recently, Suzuki et al (2007) had elegantly
demonstrated that leptin stimulated fatty acid oxidation. Martin et al (2006) found that
mice fed high-fat diet for about 10 weeks develop defective responses to leptin-
induced stimulation of fatty acid oxidation.
Our findings of the expression levels of the hepatic genes involved in fatty acid
oxidation as well as the leptin receptor in the livers of the mice fed on the high-fat,
calorie dense diet for 2 weeks supported the above proposed model. We found
increased protein levels of carnitine palmitoyltransferase 1a in the livers of the mice
fed for 2 weeks on the high-fat, calorie-dense diet as compared to their controls. This
enzyme catalyses the rate-limiting step of mitochondrial fatty acid oxidation. We also
observed increased mRNA levels of leptin receptor in the livers of the mice fed on the
high-fat, calorie-dense diet for 2 weeks.
Breakdown in compensatory responses with prolonged high-fat, calorie-dense feeding
In comparison to the observations during the initial period of the high-fat, calorie-
dense feeding, the findings with prolonged feeding suggest a possible breakdown in
the initial compensatory mechanisms in regulating food intake, lipid homeostasis and
body weight (Figure 4.31). 10 weeks of high-fat, calorie-dense feeding whilst
continuing to induce increased plasma leptin levels in the mice did not prevent a
reduction in food intake, weight gain or white adipose tissue mass deposition. Instead,
food intake, weight gain and white adipose tissue were all significantly increased in
the high-fat, calorie-dense group of mice as compared to their controls. One possible
explanation could be that these mice might have developed leptin resistance.
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Currently, suppressors of the cytokine signalling family 3 (Socs-3) is most associated
with the inhibition of leptin receptor signal transduction and has been suggested to
play a role in mediating leptin resistance in diet-induced obesity (Lavens et al., 2006).
A possible way of interpreting our observations made during prolonged high-fat,
calorie-dense feeding could be that Socs-3 exerted its inhibitory actions on the
JAK/STAT signalling, resulting in a suppression of fatty acid oxidation and increased
lipogenesis in the livers of these mice. This was supported by our observations that
with prolonged high-fat feeding, the mice at week 10 did not continue to show any
reduced mRNA levels of Socs-3 whereas Soc-3 was initially down-regulated by 3 fold
at week 2 in the high-fat group.
The inhibition of leptin signalling could possibly result in a suppression of hepatic
fatty acid oxidation. Indeed, at week 10, the genes involved in hepatic fatty acid
oxidation were no longer up-regulated. In turn, this reduced hepatic fatty acid
oxidation could have reduced the feedback stimulus to reduce food intake, resulting in
increased food intake observed in these mice.
At week 10, we observed increased mRNA levels of lipogenic genes. This might also
be a possible consequence of reduced leptin signalling with prolonged high-fat,
calorie dense feeding. The anti-lipogenic role of leptin was demonstrated by various
studies (Bai et al., 1996; Bryson et al., 1999; Soukas et al., 2000; Lee et al., 2000).
This could also possibly explain the elevated triglyceride levels in the HFC-10wk
mice. In addition, increased hepatic lipogenesis in itself, could also further inhibit
hepatic fatty acid oxidation as discussed in previous sections.
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In addition to large increase in body weight and accumulation of body fat as white
adipose tissue in the group of mice fed with high-fat, calorie-dense for 10 weeks, we
observed significant increase in their blood triglyceride levels, blood glucose levels
and plasma insulin levels. These observations share many similarities to those
metabolic abnormalities associated with the human metabolic syndrome in humans.
These observations closely reflect the pathogenesis of metabolic syndrome in humans.
Could the proposed model provide an insight to the link between a breakdown in
regulating energy homeostasis and the metabolic syndrome?
Recently, it is proposed that lipids stored in white adipose tissue might be less
harmful than being stored in non-adipose tissue (Slawik and Vidal-Puig, 2006). This
concept known as “lipotoxicity” suggests that the various metabolic abnormalities
associated with metabolic syndrome may be due to the adverse effects of fat
accumulation in the non-adipose tissues (e.g. liver). Our rudimentary model could
possibly contribute to the understanding of lipotoxicity. Roger Unger has suggested
that white adipose tissue secrete leptin to prevent the over-accumulation of
triglycerides in non-adipose tissues (e.g. liver) and thus confine fat storage to adipose
tissue only (Unger et al., 1999). This protective action of leptin works by reducing
lipogenesis and increasing oxidation in non-adipose tissues during overnutrition,
dissipating the unneeded energy of excess fatty acid as heat. This limits fatty acid
entry into potentially toxic nonoxidative metabolic pathways (Unger and Zhou, 2001).
In our proposed model, with prolonged high-fat, calorie-dense feeding, leptin
resistance occurred, with reduced sensitivity to leptin actions in the non-adipose
tissue, leading to increased lipogenesis and reduced fat breakdown. In turn, this
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resulted in overloading of triglycerides in the non-adipose tissue such as liver. In line
with the current concept on lipotoxicity, this could lead to an overload in lipid stores
in non-adipose tissue (e.g. liver), leading to cell dysfunction or lipid-induced
programmed cell death. Our suggestion that there could be liver lipotoxicity
accompanying increased lipogenesis observed in Week 4 and Week 10 HFC groups
would have been further supported by underlying hepatic pathological changes (i.e.
fatty livers).
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SEQUENTIAL EFFECTS OF A HIGH-FIBER DIET CONTAINING
PSYLLIUM HUSK ON BODY WEIGHT, PLASMA LIPIDS AND HEPATIC
GENE EXPRESSION LEVELS
INTRODUCTION
The health benefits of increased dietary fiber intake include reducing the risks of
developing cardiovascular disease, colon cancer and obesity. Greater details have
been discussed in Chapter 2. In spite of this, the literature on dietary fiber and gene
expression remains limited as compared to the literature regarding dietary fat and
gene expression. Studies examining the effects of dietary fiber on gene expression are
limited to the gastrointestinal tract (Nguyen et al., 2006; Young et al., 2005; Chapkin
et al., 1998) or only on one or two hepatic genes (Yang et al., 2003; Goel et al., 1999;
Sonoyama et al., 1995). To date, no microarray transcription profiling studies have yet
been carried out to examine the effects of dietary fiber on global hepatic gene
expression. We aimed to characterize the expression levels of hepatic genes involved
in lipid metabolism over 10 weeks of high-fiber feeding. In parallel, we examined the
changes in food intake, body weight and plasma lipids levels.
The high-fiber diet used in the experiment consisted of 10% of psyllium husk, a
soluble fiber. The control diet used was standard AIN93M. Details of the diets are
found in Chapter 3. In parallel, we examined the changes in food intake, body weight
and plasma lipids levels.
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The abbreviations used to name the groups are as follows: Mice fed on the high-fiber
diet consisting of psyllium husk for 3 weeks (PE-3wk) and for 10 weeks (PE-10wk).
The abbreviations for their respective controls are as follows: C-3wk and C-10wk.
RESULTS
Food and energy intake
At week 3, food intake was significantly reduced in the high-fiber fed mice (2.76 ±
0.06 g/day) as compared to the food intake in their controls (2.92 ± 0.08 g/day) (Table
5.1). With this reduction in food intake, PE-3wk mice also had a significantly lower
energy intake as compared to the controls (38.1 ± 0.9 kJ/day versus 44.3 ± 0.9
kJ/day). At week 10, we observed a small but significant increase in food intake in the
high-fiber fed mice as compared to the controls. However, there were no significant
differences in the energy intake between PE-10wk as compared to C-10wk mice.
Throughout the entire feeding study, fiber intake was significantly three times higher
in both the PE groups as compared to their respective controls.
Body Weights
At the start of the feeding period, there were no significant differences in the body
weights between PE-3wk mice versus C-3wk mice ( 17.0 ± 0.9 g versus 17.8 ± 0.5 g,
respectively) and PE-10wk mice versus C-10wk mice (16.9 ± 1.6 g versus 17.5 ± 1.4
g, respectively). Fiber-feeding did not seem to affect the body weights as there were
no significant differences in the final body weight between the PE-groups and their
respective controls at weeks 3 and 10 (Table 5.1). Although PE-3wk mice gained
slightly less weight from their initial body weights (0.5 ± 0.4 g) as compared to the C-
3wk mice (0.6 ± 0.4 g) mice, this was not significantly different. At week 10, there
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were also no significant differences in weight gained between PE-10wk mice versus
C-10wk mice (2.8 ± 1.3 g versus 2.3 ± 1.2 g respectively).
White adipose tissue mass
The white adipose tissue mass in the PE-3wk mice (0.16 ± 0.03g) was lower as
compared to C-3wk mice (0.18 ± 0.01g) but this was not statistically significant. At
week 10, there was no observable difference between the PE and C mice (Table 5.1).
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Table 5.1 Food intake, energy intake, body weight and white adipose tissue mass of control and high-fiber fed mice
C: control diet groups; PE: high-fiber containing psyllium husk diet groups. Values are expressed as means + SD (n= 6/group); ** denotes P <
0.01 compared to corresponding C group.
PE-3wk mice C-3wk mice PE-10wk mice C-10wk mice
Food intake (g) 2.76 ± 0.06** 2.92 ± 0.08 3.24 ± 0.14** 3.01 ± 0.04
Energy intake (kJ) 38.1 ± 0.9 ** 44.3 ± 0.9 44.8 ± 2.0 45.7 ± 0.6
Final Body Weight (g) 17.5 ± 1.3 18.4 ± 0.7 19.6 ± 0.5 19.8 ± 0.3
Gain in body weight (g) 0.5 ± 0.4 0.6 ± 0.4 2.8 ± 1.3 2.3 ± 1.2
White adipose tissue mass (g) 0.16 ± 0.03 0.18 ± 0.01 0.26 ± 0.02 0.26 ± 0.05
123
Plasma cholesterol levels
At the start of the feeding study, there were no significant differences in the plasma
total cholesterol, HDL cholesterol, LDL cholesterol and triglyceride levels in the PE
groups versus their respective controls.
The total cholesterol levels were significantly reduced in the PE-3wk group as
compared to C-3wk mice. The levels were reduced by 27% from 2.02 ± 0.08 mmol/L
(C-3wk mice) to 1.49 ± 0.18 mmol/L (PE-3wk mice) (Figure 5.1). At week 10, the
total cholesterol levels remained significantly lower in the high-fiber fed mice as
compared to their controls (1.39 ± 0.06 mmol/L versus 2.14 ± 0.22 mmol/L,
respectively). There was no significant reduction in total cholesterol levels between
the high-fiber fed mice at week 3 and week 10.
We observed that the LDL cholesterol levels were lowered from 0.42 ± 0.14 mmol/L
in the C-3wk mice to 0.30 ± 0.09 mmol/L in the PE-3wk mice (Figure 5.1). Levels
dropped from 0.44 ± 0.18 mmol/L in C-10wk mice to 0.39 ± 0.08 mmol/L in PE-
10wk mice. Both these reductions in LDL levels did not reach statistical significance.
There were also no significant differences between both high-fiber groups.
Significant reductions in HDL cholesterols were observed in the high-fiber fed groups
as compared to their controls (Figure 5.1). Since lower total cholesterol levels
(confers reduced cardiovascular risks) are usually accompanied by reduced HDL
cholesterol levels (reduced HDL cholesterol levels confers greater cardiovascular
risks), we calculated the total/HDL cholesterol ratio to resolve this dilemma (Figure
5.1). When we compared the total cholesterol/HDL cholesterol ratios, there was a
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marginally lower ratio (not significant) in the PE-3wk mice (1.27 ± 0.11) compared to
the C-3wk mice (1.25 ± 0.06). In contrast, the ratio appeared to increase in the PE-
10wk mice (1.40 ± 0.11) versus C-10wk mice (1.26 ± 0.10) (non-significant). There
were no significant differences in the ratio between both the high-fiber groups.
Plasma triglyceride levels
We observed a slight and non-significant reduction in plasma triglyceride levels in
PE-3wk (0.93 ± 0.13 mmol/L) versus C-3wk mice (0.99 ± 0.11 mmol/L) (Figure 5.2).
The plasma triglyceride fell further as the high-fiber feeding continued. The plasma
triglyceride levels were significantly reduced in the PE-10wk mice. The levels fell by
32% from 0.79 ± 0.10 mmol/L ( C-10wk mice) to 0.53 ± 0.05 mmol/L (PE-10wk
mice). The triglyceride levels in the PE-10wk mice were significantly lower than the
levels in the PE-3wk mice.
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Figure 5.1 Plasma cholesterol levels from control and high-fiber mice
C: control diet groups; PE: high-fiber containing psyllium husk diet groups. Values are expressed as means + SD (n= 6/group)
* denotes P < 0.05 compared to corresponding C group. Circles with dotted lines represent data from C mice. Squares with solid lines represent





















































































































Figure 5.2 Plasma triglyceride levels from control and high-fiber mice
C: control diet groups; PE: high-fiber containing psyllium husk diet groups. Values
are expressed as means + SD (n= 6/group); * denotes P < 0.05 compared to
corresponding C group. φ denotes P < 0.05 compared to PE-3wk group. Circles with
dotted lines represent data from C mice. Squares with solid lines represent data from
PE mice. Data at the week 0 (i.e. start of the feeding period) is calculated from the
































Microarray profiling of hepatic gene transcription levels over the duration of
high-fiber feeding
The differential gene expression levels were analysed according to the following pair-
wise comparisons. For example, hepatic gene expression levels in mice fed on high-
fiber diet for 3 weeks (PE-3wk) were compared to the levels observed in the mice fed
on control diet for 3 weeks (C-3wk). Similar comparisons were carried out for mice at
week 10 (i.e. PE-10wk versus C-10wk).
Hepatic genes involved in fatty acid oxidation and lipogenesis
At week 3, genes involved in -oxidation of fatty acids such as Acox1, Acaa2, Acsl1,
Acsl4, Crat, Cpt1a, Ehhadh, Hadhb, Pte2b, were all up-regulated in the PE-3wk mice
(Figure 5.3A). Cpt1a, the gene encoding the rate-limiting enzyme for fatty acid
oxidation, was up-regulated by 1.6 fold. Concomitant with the up-regulation of genes
involved in fat breakdown, genes encoding enzymes involved in lipid biosynthesis
were down-regulated (Figure 5.3B). These included Srebp1, Bucs1, Dgat2 and Fasn.
Srebp1, which was largely suppressed by 3.7 fold, is a membrane-bound transcription
factor that enhances transcription of genes required for fatty acid synthesis. Fasn, a
key gene in fatty acid biosynthesis was highly repressed by 4 fold (Figure 5.3B).
After 10 weeks of high-fiber feeding, genes involved in fatty acid -oxidation were no
longer up-regulated and in some, were actually down-regulated (e.g. Cpt1a, Cpt2 and
Dci) (Figure 5.3A). Pparα, which controls the peroxisomal beta-oxidation pathway of
fatty acids, was down-regulated by 2.3 fold. Some of the down-regulated genes
involved in fatty acid biosynthesis (e.g. Fasn and Acly) at week 3 were found to be
up-regulated after 10 weeks of high-fiber diet. Fasn was up-regulated by 1.7 fold
128
(Figure 5.3B). Other genes such as Scd1, Ptgs1 and Alox5ap which were involved in
fatty acid biosynthesis were also up-regulated.
Hepatic genes involved in cholesterol metabolism
After 3 weeks of high-fiber feeding, 3 genes involved in cholesterol synthesis
pathway (Hmgcs1, Hsd17b7 and Cyp51) were up-regulated by 1.6 fold, 1.5 fold and
1.9 fold respectively (Figure 5.3C). The mice fed on 10 weeks of high-fiber diet
continued to show an up-regulation for these 3 genes with a greater increase in
Hmgcs1 (2 fold) and Cyp51 (2.2 fold) as compared to their controls. In addition at
week 10, more genes involved in the cholesterol biosynthesis pathway, such as
Nsdh1, Hmgcr, Idil, Sc4mol, Stard4 and Dhcr7 were also up-regulated in the PE-
10wk group (Figure 5.3C). Hmgcr, which encodes the rate-limiting enzyme for
cholesterol synthesis, was up-regulated by 2 fold at week 10. None of the genes
involved in the cholesterol synthesis pathway were down-regulated at both time-
points.
Hepatic genes involved in bile acid synthesis
The gene encoding the rate-limiting enzyme involved in bile acid synthesis, Cyp7a1,
was highly up-regulated by 3.3 fold in the PE-3wk mice (Figure 5.3C). However,
Cyp7a1 expression was down-regulated by 1.4 fold after 10 weeks of high-fiber
feeding enriched with psyllium husk as compared to the control group. HNF4, a key
hepatic transcription factor which can regulate Cyp7a1 had increased expression in
both PE-3wk and PE-10wk mice by 1.6 and 1.5 fold respectively. Cyp39a1 is also
involved in the conversion of cholesterol to bile acids. Its substrates include
oxysterols such as 25-hydroxycholesterol, 27-hydroxycholesterol and 24-
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hydroxycholesterol. It has been shown that Cyp39a1 has a preference for the substrate
24-hydroxycholesterol. Its expression was elevated in the livers of both PE-3wk and
PE-10wk mice by 2.3 fold and 1.7 fold respectively.
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Figure 5.3 Hepatic genes involved in lipid metabolism regulated by high-fiber
feeding at weeks 3 and 10.
The colour-coded scale (green=down-regulation and red=up-regulation). Data of “fold
change” were calculated from the “Signal Log Ratio”. The scale is presented as fold
change.
(A) Genes involved in fatty acid oxidation
(B) Genes involved in lipogenesis
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Figure 5.3 (continued) Hepatic genes involved in lipid metabolism regulated by
high-fiber feeding at weeks 3 and 10.
(C) Genes involved in cholesterol metabolism and bile acid synthesis
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Expression levels of hepatic genes involved in lipid metabolism measured by
quantitative RT-PCR
We validated our microarrays findings by conducting real-time PCR assays on
selected genes such as Cpt1, Fasn, Hmgcr, Cyp7a1 and Pparα. These genes were
selected as they encode enzymes regulating the key steps of lipid metabolism. For
instance, Cpt1a is the gene encoding the rate-limiting enzyme for mitochondrial fatty
acid oxidation, Fasn encodes a key lipogenic enzyme, Hmgcr encodes the rate-
limiting enzyme for cholesterol synthesis. Cyp7a1 encodes the enzyme regulating the
rate-limiting step in the neutral pathway of bile acid synthesis. The individual melting
curves are presented in Appendix 4.2. The gel electrophoresis of the amplified PCR
products is found in Appendix 4.3.
Figure 5.4 presents the gene expression levels of Cpt1L, Fasn and Pparα measured by
quantitative RT-PCR. There was a slight but non-significant reduction in the
expression of Cpt1a in the mice fed for high-fiber for 3 weeks. At week 10, the high-
fiber fed mice showed an increase in their gene expression of Cpt1a as compared to
the control mice (non-significant). There was a tendency for the high-fiber fed mice to
have a lower expression of Fasn at week 3 but this was not statistically significant
from the controls. However, at week 10, we observed a significant increase in Fasn
expression levels in the high-fiber fed mice. There were no significant differences in
Pparα expression levels between the high fiber mice and their corresponding controls
at both weeks 3 and 10.
Figure 5.5 presents the gene expression levels of Hmgcr and Cyp7a1 measured by
quantitative RT-PCR. Both PE groups had significantly higher expression of Hmgcr
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than their respective control groups (P < 0.05). The PE-3wk mice had significantly
higher mRNA levels of Cyp7A1 as compared to the C-3wk mice. At week 10, the
expression levels of Cyp7A1 were lower in PE-10wk versus C-10wk (not significant).
Figure 5.4 Gene expression levels of Cpt1a, Fasn and Pparα measured by
quantitative RT-PCR in liver tissues from control and high-fiber mice at both
time-points.
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Figure 5.5 Gene expression levels of Hmgcr and Cyp7a1 measured by
quantitative RT-PCR in liver tissues from control and high-fiber mice at both
time-points.









































Western blot assays of 3-hydroxy-3-methylglutaryl-coenzyme reductase and
fatty acid synthase
We verified the differential expression of Hmgcr and Fasn at the protein levels by
Western blot analysis. The individual gel electrophoresis samples run together with
the protein markers are shown in Appendix 5.1. We demonstrated that the PE-10wk
group had significantly higher protein expression levels of Hmgcr as compared to the
C-10wk group (Figure 5.6). There was no observable difference in protein expression
in the PE-3wk group versus the C-3 wk group (data in Appendix 5.1). We also
showed that the PE-3 wk group had a significantly lower expression of Fasn protein
levels as compared to the C-3week group. At week 10, we observed increased Fasn
protein levels in the high-fiber mice (Figure 5.7).
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Figure 5.6 Western blot analysis of 3-hydroxy-3-methylglutaryl-coenzyme
reductase (Hmgcr) in the livers from control mice and mice fed on psyllium husk
(A) Western blot analysis of Hmgcr in the livers from control mice (odd-
numbered lanes) and mice fed on psyllium husks for 10 weeks (even-
numbered lanes) (n = 4 mice/group)
(B) Optical density analysis of Hmgcr bands normalized by B-actin bands in
the controls compared to the PE-fed group. Each bar represents means ±
SD (for each group of mice n = 4) *: P < 0.05 as compared to control group.
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Figure 5.7 Western blot analysis of fatty acid synthase (Fasn) in the livers from
the control mice and mice fed on psyllium husk
(A) Western blot analysis of Fasn in the livers from the 3-week control mice
(odd-numbered lanes) and mice fed on psyllium husk for 3 weeks (even-
numbered lanes) (n = 4 mice/group)
1 2 3 4 5 6 7 8
Fasn
B-actin
(B) Western blot analysis of Fasn in the livers from the 10-week control group
(odd-numbered lanes) and mice fed on psyllium husk for 10 weeks (even-
numbered lanes) (n = 4 mice/group)




Figure 5.7 (continued) Western blot analysis of fatty acid synthase (Fasn) in the
livers from the control mice and mice fed on psyllium husk
(C) Optical density analysis of Fasn bands normalized by B-actin bands in the
controls compared to the corresponding PE-fed groups
Each bar represents means ± SD (for each group of mice n = 4)
*: P < 0.05 as compared to control group.










































Sequential effects of a high-fiber diet on food intake and body weight
We observed that the high-fiber fed mice had a lower food intake initially at week 3
but this reduced food intake was not maintained with prolonged high-fiber feeding.
Our findings also revealed that a diet high in fiber enriched with psyllium husk did
not promote weight loss as the weights of both the PE groups were comparable to the
control groups. It was notable that while we observed a reduction in PE-3wk mice
energy intake, there was no significant weight loss in them. Since the average energy
cost of weight loss is known to be about 30 kJ per gram of body weight, the expected
average weight loss in the PE-3wk group should be about 4 grams in the mice over
the 3 weeks of high-fiber feeding. Besides the absence of weight loss, the PE-3wk
mice had increased their body weights by 0.5 ± 0.4g instead. Therefore, our data over
the entire fiber feeding period did not seem to support the theory suggested by others
(Krotkiewski, 1984; Raben et al, 1994) that consumption of a high-fiber diet
containing viscous soluble fiber would promote weight loss.
Sequential effects of a high-fiber diet on plasma lipids and hepatic gene
expression levels
In relation to plasma lipids, the beneficial effects of consuming a high-fiber diet
containing psyllium husk were more evident. Within 3 weeks of starting the high-
fiber diet, total cholesterol levels were significantly lower than the control mice. The
total cholesterol levels remained suppressed with prolonged high-fiber feeding.
However, there was no further significant reduction as the feeding period continued.
We observed a significant reduction in the HDL cholesterol but not in the LDL
cholesterol levels in the high-fiber groups. Perhaps, this could be due to the fact that
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major fraction of plasma cholesterol in mice is HDL and not LDL. This could be
because mice do not have plasma cholesterol ester transfer protein (CETP) activity.
There are 2 major suggested mechanisms through which soluble fiber can reduce
cholesterol. These are either by the inhibition of hepatic cholesterol synthesis or by
greater rate of clearance with increased bile acid synthesis. With regards to
cholesterol synthesis, we found that none of the genes involved in hepatic cholesterol
biosynthesis were down-regulated after high-fiber feeding at both time-points.
Instead, genes involved in cholesterol synthesis were found to be up-regulated at
week 3. Additional genes were up-regulated at week 10. Some even showed further
increases in their gene expression levels. These gene expression levels were further
verified by the western blot assay of Hmgcr. Hmgcr encodes the rate-limiting enzyme
for cholesterol synthesis. Its protein levels were significantly higher in the high-fiber
fed mice at week 10 as compared to the controls. This might be a possible response by
the mice to adapt to the reduced plasma cholesterol levels. Miettinen and Tarpila
(1989) had suggested that cholesterol synthesis could increase to offset fecal sterol
losses when hyperlipidemic subjects were fed soluble viscous fiber. Our observations
of the hepatic genes involved in cholesterol synthesis at the mRNA level provided
further molecular evidence for their work.
On the other hand, our transcription profiling of the livers showed molecular evidence
supporting the concept that there was increased bile acid synthesis in mice fed with
high fiber enriched with psyllium husk, as evidenced by the changes in genes such as
Cyp7A1, Cyp39A1 and Ldlr. Cyp7A1 governs the rate-limiting step in the neutral
pathway of bile acid synthesis from cholesterol. In the liver, cholesterol is converted
to bile acids. This removes it from the active cholesterol pool and results in an up-
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regulation of hepatic low-density lipoprotein receptors (Ldlr) and decreased plasma
cholesterol levels. Cyp7A1 was highly up-regulated in the PE-3wk mice and this was
also confirmed by RT-PCR performed on the individual mRNA samples from the PE-
3wk mice. Our observation on the increased expression levels of Cyp7a1 in the PE-
3wk mice are in agreement with findings reported by Yang et al (2003). They found
increased Cyp7a1 mRNA levels in rats fed on barley (which is also high in viscous
soluble fiber) for 2 weeks. However, it was notable that the prolonged high-fiber
feeding induced a downward trend in Cyp7a1 mRNA levels. The suppressed Cyp7a1
mRNA levels at week 10 could be due to feedback inhibition by the bile acids
returning to the liver via enterohepatic circulation.
In addition to Cyp7a1, we found that the PE mice had elevated mRNA levels of
Cyp39a1. Cyp39a1 preferentially converts 24-hydroxycholesterol into bile acids as
well. Recently, there were numerous studies which suggested a pivotal role of 24-
hydroxycholesterol in the link between increased cholesterol levels and the risk of
developing Alzheimer's disease, as reviewed by Bjorkhem and colleagues (2006).
There is evidence to suggest that the plasma levels of 24-hydroxycholesterol are
higher in patients with Alzheimer's disease compared to healthy subjects (Bjorkhem et
al., 2006). Our findings with regards to the increased expression levels of Cyp39a1
could possibly highlight another potential benefit of consuming a high-fiber diet
enriched with soluble viscous fiber. Our observations suggested that the lowering of
plasma cholesterol by psyllium husk could also likely be exerted at a more upstream
level of transcription, that is, through the up-regulation of HNF4. HNF4 is a key
hepatic transcription factor which can regulate the expression of Cyp7A1 (Hayhurst et
al., 2001).
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Although both groups of PE mice did not show any reduced expression of hepatic
genes involved in cholesterol synthesis, genes related to lipogenesis were down-
regulated at week 3 in the high-fiber fed mice. On the other hand, the genes involved
in fatty acid oxidation were up-regulated in PE-3wk mice as compared to C-3wk.
However, these trends reversed at week 10. The transcription profiling of the mice
livers revealed that prolonged high-fiber feeding resulted in increased mRNA levels
of lipogenic genes and reduced mRNA levels of genes involved in fatty acid
oxidation. The western blot assays of Fasn, a key gene involved in lipogenesis were
also in agreement with its gene expression levels. Its protein levels were significantly
lower in the livers of the high-fiber fed mice as compared to the controls at week 3.
However, Fasn protein levels were significantly raised with prolonged high-fiber
feeding. These differential mRNA levels of the genes involved in lipogenesis
suggested that it could be possible that the mice were attempting to adapt to the
reduced plasma triglyceride levels. This could also possibly indicate that non-adipose
tissue, such as the liver, was responding by regulating their triglyceride content.
In summary, our study sequentially examined the effects of high-fiber feeding
enriched with psyllium husk. Whilst body weight was unaffected, plasma cholesterol
and triglycerides levels were reduced by feeding such a diet. We reported novel
findings that a high-fiber diet enriched with psyllium husk could differentially
regulate the expression of hepatic genes involved in lipogenesis as well as cholesterol
synthesis. The early response to high-fiber diet aimed at reducing mRNA levels of
lipogenic genes and increasing mRNA levels of lipolysis genes, changed after a
longer period of high-fiber feeding period. This suggested that different mechanism
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may be implemented to adapt the lipid metabolism when there were decreased fat
stores in the body. The increased mRNA levels of hepatic genes involved in
cholesterol synthesis throughout the whole entire feeding period could possibly
suggest a robust regulatory mechanism in place to regulate plasma cholesterol levels.
This could also explain why further significant reduction in plasma cholesterol levels
was not observed in the PE-10wk mice as compared to the PE-3wk mice.
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CHAPTER 6
CONCLUSIONS AND FUTURE RECOMMENDATIONS
CONCLUSIONS
The results obtained from the study on the sequential effects of a high-fat, calorie-
dense diet supported our initial hypothesis that the early responses to a high-fat and
calorie-dense diet, aimed at using the energy surplus and to prevent excessive fat
deposition, changed after a long-term feeding period. Subsequently, it appeared that
different mechanisms involved in lipid metabolism in the liver and leptin signalling
might possibly be implemented to adapt metabolism for the deposition of body fat
with the continued excessive fat and energy intake. Based on our observations, we
have proposed a possible model linking the various observations on how a high-fat,
calorie-dense diet could have contributed to the various metabolic irregularities.
These metabolic irregularities are commonly associated with obesity. These effects
are clearly dependent on the duration of the high-fat, calorie-dense diet and became
evident when the mice’s initial compensatory adaptations failed beyond 4 weeks. It
was only after 4 weeks of high-fat, calorie-dense feeding then we observed a marked
increase in deposition of white adipose tissue. Our results could possibly help to
explain the apparently discrepant findings in regulation of food intake by leptin as
well as the gene expression levels involved in lipid metabolism in liver and white
adipose tissue. Our findings also suggested that the homeostatic processes aimed at
maintaining energy balance, weight gain and plasma cholesterol levels could also be
reflected at the gene transcription and protein levels. Such findings have not been
previously described.
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In the study on the effects of a high-fiber diet consisting of psyllium husk, contrary to
expectations, we found that the hepatic gene transcription profile was one which
seemed to be aimed at preventing the lowered plasma levels of cholesterol to be
further reduced. Similarly, the gene expression levels of lipogenic genes were also up-
regulated with prolonged high-fiber feeding. The contrasting observations in the gene
expression levels between these two different diets (i.e. the high-fat, calorie-dense diet
and the high-fiber diet) suggested that the expression levels of the genes appeared to
be rigorously regulated to ensure that our bodies would always have sufficient lipid
stores regardless of abundance (as induced by high-fat, calorie dense feeding) or in
deficiciency (as induced by high-fiber feeding).
FUTURE RECOMMENDATIONS
Quantification of Cpt1L, Fas, Lepr, Socs3 mRNA levels in the hypothalamus
In this thesis, we have examined the expression levels of the following genes in the
liver and adipose tissue (i.e. Cpt1L, Fas, Lepr, Socs3). These novel findings have
shown that the expression levels of these genes were differentially regulated over the
entire HFC feeding period and these genes could also possibly play a role in
regulating the feeding behaviour as well as the energy homeostasis in the mice,
exerting their influence outside the central nervous system. It is known that leptin
reduces the hypothalamic expression of neuropeptide Y, the effector stimulating food
intake. In addition, it has also been documented that the inhibition of hypothalamic
Cpt1 activity was sufficient to diminish food intake (Obici et al., 2003). Examining
the transcription profiling of the hypothalamic expression of these genes concurrently
with the profile of our current reported findings could lead to a better understanding
of the regulation of food intake in the mice over the entire feeding period.
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Measurement of the lipid fluxes
Although we have confirmed and validated the differentially expression of the genes
as well as the enzyme concentrations of these proteins encoded by these genes
involved in lipid metabolism, these changes may not actually reflect the lipid
metabolism fluxes in the mice. For instance, cofactors or the availability of metabolic
substrates could affect lipid metabolic pathways, independent of these enzyme levels.
Alternatively, the enzyme activities could also be regulated allosterically. Therefore,
it is suggested that further work to conduct direct measurements of these lipid fluxes
(e.g. measurement of triglyceride synthesis and degradation (lipolysis) be conducted
to gain a better insight.
Analysis of other differentially expressed genes
This study has selected a few key genes encoding well-studied enzymes regulating
key steps of lipogenesis, cholesterol synthesis and fatty acid ovidation to carry further
validation with qRT-PCR experiments. It will also be interesting to examine
differentially regulated genes involved in other aspects of lipid metabolism (namely
phospholipid, sphingolipid and eicosanoid metabolism). Moreover, the gene
expression profiling of the livers and the adipose tissue also showed differential
expression of genes involved in cell cycle, stress signalling and inflammatory
pathways. The detailed analysis of these other genes could provide valuable insights
into the other detrimental effects of consuming a high-fat, energy dense diet which
could be related to the onslaught of the other chronic nutrition-related diseases.
Moreover, a significant number of the differentially expressed genes examined do not
have known functional ontology. To identify their possible functions, principle
component anaylsis or hierarchical clustering, which maps these novel genes to genes
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with known function, could be useful. This is an attractive strategy, as it can
potentially lead to the discovery of novel genes.
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NUTRIENT COMPOSITION OF THE DIETS USED
Nutrient composition of the high-fat, calorie-dense diet (Specialty Feeds, SF 00-
219)
This diet for laboratory mice and rats was formulated to mimic a “Western fast food
diet”. This diet was designed to be equivalent to Harlan Teklad TD88137 or Research
Diets Western Diet D12079B.
Nutritional parameters
Protein 19 %
Total Fat 21 %
Crude Fibre 4.7 %
Acid Detergent Fibre 4.7 %
Digestible Energy 19.4 MJ / Kg
Ingredients
Casein (Acid) 195 g/Kg
DL Methionine 3.0 g/Kg
Sucrose 341 g/Kg
Wheat Starch 154 g/Kg
Cellulose 50 g/Kg
Clarified Butter (Ghee) 210 g/Kg
Calcium Carbonate 17.1 g/Kg
Sodium Chloride 2.6 g/Kg




Pottasium Sulphate 1.6 g/Kg
AIN93G Trace minerals 1.4 g/Kg
Choline Chloride (65%) 2.5 g/Kg
SF00-219 Vitamins 10 g/Kg
USP Cholesterol 15 g/Kg





















Iron 90 mg / Kg
Copper 6.7 mg / Kg
Iodine 0.22 mg / Kg
Manganese 20 mg / Kg
Cobalt No data
Zinc 40 mg / Kg
Molybdenum No data
Selenium 0.15 mg / Kg
Cadmium No data
Chromium 2.0 mg / Kg
Lithium 0.1 mg / Kg
Boron 0.7 mg / Kg
Nickel 0.55 mg / Kg
Vanadium 0.10 mg / Kg
Total Vitamins
Vitamin A (Retinol) 10,000 IU / Kg
Vitamin D3
(Cholecalciferol)
1,100 IU / Kg
Vitamin E (a Tocopherol
acetate)
62 mg / Kg
Vitamin K (Menadione) 12 mg / Kg
Vitamin C (Ascorbic
acid)
700 mg / Kg
Vitamin B1 (Thiamine) 11 mg / Kg
Vitamin B2 (Riboflavin) 11 mg / Kg
Niacin (Nicotinic acid) 50 mg / Kg
Vitamin B6 (Pyridoxine) 11 mg / Kg
Pantothenic acid 33 mg / Kg
Biotin 200 ug / Kg
Folic acid 1 mg / Kg
Inositol 55 mg / Kg
Vitamin B12
(Cyanocobalamin)
18 mg / Kg
Choline 2,500 mg / Kg
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Fat Composition
Saturated fats C12:0 or less 2.4 %
Myristic Acid 14:0 2.3 %
Palmitic Acid 16:0 6.1 %
Stearic Acid 18:0 1.9 %
Arachidic Acid 20:0 0.5 %
Palmitoleic Acid 16:1 1.0 %
Oleic Acid 18:1 5.6 %
Gadoleic Acid 20:1 trace
Linoleic Acid 18:2 n6 0.8 %
a Linolenic Acid 18:3 n3 trace
Arachadonic Acid 20:4 n6 No data
EPA 20:5 n3 No data
DHA 22:6 n3 No data
Total Carotenoid No data
Total Phospholipid No data
Cholesterol 0.15 %
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Nutrient composition of the control diet used in high-fat, calorie-dense diet
experiment (Specialty Feeds, Meat free rat and mouse)
A fixed formulation diet for Laboratory Rats and Mice fortified with vitamins and
minerals to meet the requirements of breeding animals. The formulation is designed to
be fed ad-libitum to rodents of all ages.
Nutritional parameters
Protein 19.0 %
Total Fat 4.6 %
Crude Fibre 4.5 %
Digestible Energy 14.3 MJ / Kg
Trace Minerals
Magnesium 100 mg / Kg
Iron 70 mg / Kg
Copper 16 mg / Kg
Iodine 0.5 mg / Kg
Manganese 70 mg / Kg
Zinc 60 mg / Kg
Molybdenum 0.5 mg / Kg
Selenium 0.1 mg / Kg
Vitamins




Vitamin K (Menadione) 2 mg / Kg
Vitamin E (aTocopherol
acetate)
100 mg / Kg
Vitamin B1 (Thiamine) 6 mg / Kg
Vitamin B2 (Riboflavin) 6 mg / Kg
Niacin (Nicotinic acid) 25 mg / Kg
Vitamin B6 (Pyridoxine) 6 mg / Kg
Calcium Pantothenate 20 mg / Kg
Biotin 100 ug / Kg
Folic acid 2 mg / Kg
Vitamin B12
(Cyanocobalamin)














Vitamin A (Retinol) 10,900 IU / Kg
Vitamin D3
(Cholecalciferol)
> 2,000 IU / Kg
Vitamin E (Tocopherol) 110 mg / Kg
Vitamin K (Menadione) 2 mg / Kg
Vitamin C (Ascorbic acid) no data
Vitamin B1 (Thiamine) 10 mg / Kg
Vitamin B2 (Riboflavin) 7.3 mg / Kg
Niacin (Nicotinic acid) 70 mg / Kg
Vitamin B6 (Pyridoxine) 9 mg / Kg
Pantothenic acid 30 mg / Kg
Biotin 200 ug / Kg




30 ug / Kg









Iron 370 mg / Kg
Copper 24 mg / Kg
Iodine 0.5 mg / Kg
Manganese 340 mg / Kg
Cobalt no data
Zinc 90 mg / Kg
Molybdenum 0.5 mg / Kg




Myristic Acid 14:0 0.03 %
Palmitic Acid 16:0 0.5 %
Stearic Acid 18:0 0.15 %
Palmitoleic Acid 16:1 0.01 %
Oleic Acid 18:1 1.9 %
Gadoleic Acid 20:1 0.03 %
Linoleic Acid 18:2 n6 1.3 %
a Linolenic Acid 18:3 n3 0.3 %
Arachadonic Acid 20:4 n6 trace
EPA 20:5 n3 0.04 %
DHA 22:6 n3 0.08 %
Total Carotenoid no data
Total Phospholipid no data
Cholesterol trace
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Nutrient composition of the high-fiber diet used in high-fiber feeding experiment
(Specialty Feeds, SF03-034)
A semi-pure diet formulation for laboratory rats and mice based on AIN-93M. Fibre
content of the diet has been increased by inclusion of Psyllium husk.
Nutritional parameters
Protein 13.5 %
Total Fat 4 %
Crude Fibre 9.2 %
Acid Detergent Fibre 14.1 %
Digestible Energy 13.8 MJ / Kg
Ingredients
Casein (Acid) 140 g/Kg
DL Methionine 1.8 g/Kg
Sucrose 100 g/Kg
Wheat Starch 372 g/Kg
Dextrinised Starch 155 g/Kg
Cellulose 50 g/Kg
Psyllium Husk (95 - 98%) 100 g/Kg
Canola Oil 40 g/Kg
Calcium Carbonate 13.1 g/Kg
Sodium Chloride 2.6 g/Kg




Potassium Sulphate 1.6 g/Kg
AIN93G Trace minerals 1.4 g/Kg
Choline Chloride (65%) 2.5 g/Kg





















Iron 82 mg / Kg
Copper 6.4 mg / Kg
Iodine 0.2 mg / Kg
Manganese 15 mg / Kg
Cobalt no data
Zinc 34 mg / Kg
Molybdenum no data
Selenium 0.15 mg / Kg
Cadmium no data
Chromium 2.0 mg / Kg
Lithium 0.1 mg / Kg
Boron 0.7 mg / Kg
Nickel 0.55 mg / Kg
Vanadium 0.10 mg / Kg
Total Vitamins
Vitamin A (Retinol) 4,000 IU / Kg
Vitamin D3
(Cholecalciferol)
1,000 IU / Kg
Vitamin E (a Tocopherol
acetate)
75 mg / Kg




Vitamin B1 (Thiamine) 6 mg / Kg
Vitamin B2 (Riboflavin) 6 mg / Kg
Niacin (Nicotinic acid) 30 mg / Kg
Vitamin B6 (Pyridoxine) 7 mg / Kg
Pantothenic acid 16 mg / Kg
Biotin 200 ug / Kg




100 mg / Kg
Choline 1600 mg / Kg
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Fat Composition
Myristic Acid 14:0 trace
Palmitic Acid 16:0 0.2 %
Stearic Acid 18:0 0.1 %
Palmitoleic Acid 16:1 trace
Oleic Acid 18:1 2.4 %
Gadoleic Acid 20:1 trace
Linoleic Acid 18:2 n6 0.8 %
a Linolenic Acid 18:3 n3 0.4 %
Arachadonic Acid 20:4 n6 trace
EPA 20:5 n3 trace
DHA 22:6 n3 trace
Total Carotenoid no data
Total Phospholipid no data
Cholesterol no data
Nutrient composition of the control diet used in high-fiber feeding experiment
(Specialty Feeds, AIN-93M)




Total Fat 4 %
Crude Fibre 4.7 %
Acid Detergent Fibre 4.7 %
Digestible Energy 15.2 MJ / Kg
Ingredients
Casein (Acid) 140 g/Kg
DL Methionine 1.8 g/Kg
Sucrose 100 g/Kg
Wheat Starch 472 g/Kg
Dextrinised Starch 155 g/Kg
Cellulose 50 g/Kg
Canola Oil 40 g/Kg
Calcium Carbonate 13.1 g/Kg
Sodium Chloride 2.6 g/Kg




Potassium Sulphate 1.6 g/Kg
AIN93G Trace minerals 1.4 g/Kg
Choline Chloride (65%) 2.5 g/Kg





















Iron 82 mg / Kg
Copper 6.4 mg / Kg
Iodine 0.2 mg / Kg
Manganese 15 mg / Kg
Cobalt no data
Zinc 34 mg / Kg
Molybdenum no data
Selenium 0.15 mg / Kg
Cadmium no data
Chromium 2.0 mg / Kg
Lithium 0.1 mg / Kg
Boron 0.7 mg / Kg
Nickel 0.55 mg / Kg
Vanadium 0.10 mg / Kg
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Total Vitamins
Vitamin A (Retinol) 4,000 IU / Kg
Vitamin D3
(Cholecalciferol)
1,000 IU / Kg
Vitamin E (a Tocopherol
acetate)
75 mg / Kg




Vitamin B1 (Thiamine) 6 mg / Kg
Vitamin B2 (Riboflavin) 6 mg / Kg
Niacin (Nicotinic acid) 30 mg / Kg
Vitamin B6 (Pyridoxine) 7 mg / Kg
Pantothenic acid 16 mg / Kg
Biotin 200 ug / Kg




100 mg / Kg
Choline 1600 mg / Kg
Fat Composition
Myristic Acid 14:0 trace
Palmitic Acid 16:0 0.2 %
Stearic Acid 18:0 0.1 %
Palmitoleic Acid 16:1 trace
Oleic Acid 18:1 2.4 %
Gadoleic Acid 20:1 trace
Linoleic Acid 18:2 n6 0.8 %
a Linolenic Acid 18:3 n3 0.4 %
Arachadonic Acid 20:4 n6 trace
EPA 20:5 n3 trace
DHA 22:6 n3 trace
Total Carotenoid no data




COLLECTION OF BLOOD BY INTRACARDIAC PUNCTURE
Materials
 Disposable gloves
 Syringe (1 m1)




1. Anaesthetize mouse with the CRC mixture.
2. Lay the mouse flat on its back.
3. Sterilize the site of the needle insertion with 70% ethanol.
4. Insert the needle at the base of the sternum at a 15-20o angle just lateral of the
midline. Aspirate the syringe slowly.
5. Euthanatize the mouse
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APPENDIX 3.3
COLLECTION OF BLOOD FROM THE TAIL
Materials
 Disposable gloves
 Syringe (1 m1)




1. Anaesthetize mouse with the CRC mixture.
2. Lay the mouse flat on its back with its tail hanging down. The tail is soaked in
warm water for 5mins. Wipe it dry.
3. Sterilize the site of the needle insertion with 70% ethanol.
4. Insert the needle into the ventral artery of the tail. Aspirate the syringe slowly.
5. Collect about 0.15 ml (Maximum volume 0.2ml) of blood
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APPENDIX 3.4
EXTRACTION OF TOTAL RNA BY TRIZOL® REAGENT
Principle
TRIzol® reagent (Invitrogen) is a ready-to-use reagent for the isolation of total RNA
from cells or tissues. It contains phenol and guanidine isothiocyanate. During sample
homogenization or lysis, it maintains the integrity of the RNA, while disrupting cells
and dissolving cell components. After the addition of chloroform and followed by
centrifugation, the solution is separated into an aqueous phase and an organic phase.
RNA remains exclusively in the aqueous phase. After transfer of the aqueous phase,
the RNA is recovered by precipitation with isopropyl alcohol. Total RNA isolated by
TRIzol® reagent is free of protein and DNA contamination. The isolated RNA has a
A260/A280 ratio ≥1.8 when diluted into TE and A260/A280 ratio of 1.5-1.8 when
diluted in distilled water.
Procedures
1. HOMOGENIZATION OF THE TISSUES
Homogenize about 50mg of the liver tissue samples or about 200mg of white adipose
tissue in 1 ml of TRIzol® reagent using chilled mortar and pestle. An additional
isolation step is performed for the white adipose tissue. Following homogenization,
centrifuge the solution at 12,000 × g for 10 minutes at 4°C. A layer of fat collects as a
top layer which is removed. Transfer the cleared homogenate solution to a fresh tube
and proceed with chloroform addition and phase separation.
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2. PHASE SEPARATION
Incubate the homogenized samples for 5 minutes at room temperature (23°C) to allow
the complete dissociation of nucleoprotein complexes. Add 0.2 ml of chloroform per
1 ml of TRIzol® reagent. Cap tubes securely. Vortex tubes for 15 seconds and
incubate them at room temperature for 2 to 3 minutes. Centrifuge the samples at
12,000 × g for 15 minutes at 4°C. Following centrifugation, the mixture separates into
a lower red, phenol-chloroform phase, an interphase, and a colourless upper aqueous
phase. RNA remains exclusively in the aqueous phase.
3. RNA PRECIPITATION
Transfer the aqueous phase to a fresh tube, and save the organic phase if isolation of
DNA or protein is desired. Precipitate the RNA from the aqueous phase by mixing
with adding 0.25 ml of isopropyl alcohol and 0.25 ml of a sodium chloride sodium
citrate solution (1.2M sodium chloride and 0.8 M sodium citrate). Incubate the
samples at room temperature (23°C) for 10 minutes and centrifuge at no more than
12,000 × g for 10 minutes at 4°C. The RNA precipitate, after centrifugation, forms a
gel-like pellet on the side and bottom of the tube.
4. RNA WASH
Remove the supernatant. Wash the RNA pellet once with 75% ethanol, adding at least
1 ml of 75% ethanol per 1 ml of TRIZOL Reagent used for the initial
homogenization. Mix the sample by vortexing and centrifuge at 6000 × g for 5
minutes at 4°C.
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5. REDISSOLVING THE RNA
Remove the supernatant. Air-dry the RNA pellet briefly (5 minutes). It is important
not to let the RNA pellet dry completely as this will greatly decrease its solubility.
Dissolve RNA in RNase-free water (liver : use 60 ul of RNase-free water ; white
adipose tissue : use 30ul of RNase-free water).
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APPENDIX 3.5
PURIFICATION OF TOTAL RNA BY USING RNEASY ® MINI KIT
Principle
The RNeasy ® Mini Kit can be used to purify RNA. Guanidine isothiocyanate-
containing lysis buffer and ethanol are added to the sample to promote selective
binding of RNA to the silica-gel membranes inside the RNeasy mini columns.
Contaminants are efficiently washed away and high-quality, pure RNA is eluted in
RNase-free water.
Procedures
1. Adjust total RNA sample (not exceeding 100ug of total RNA per sample) to a
final volume of 100 ul with RNase-free water. Add 350 ul Buffer RLT
(containing guanidine isothiocyanate) and mix thoroughly.
2. Add 250 ul ethanol (96-100%) to the diluted RNA, and mix thoroughly by
pipetting.
3. Apply the sample (700 ul) to an RNeasy mini column placed in a 2 ml
collection tube. Centrifuge for 15s at >8000 x g at 23°C. Discard the flow-
through and collection tube.
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4. Transfer the RNeasy column into a new 2 ml collection tube (supplied). Pipet
500ul Buffer RPE onto the RNeasy column. Centrifuge for 15s at >8000 x g at
23°C. Discard the flow-through.
5. Add another 500 ul Buffer RPE to the RNeasy column. Centrifuge for 2 mins
at >_8000 x g to dry the RNeasy silica-gel membrane.
6. To elute, transfer the RNeasy column to a new 1.5 ml collection tube. Pipette
30 ul of RNase-free water directly onto the RNeasy silica-gel membrane.
Centrifuge for 1 min at >_8000 x g >_10,000 rpm) to elute.
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APPENDIX 3.6
PROTOCOL FOR cDNA SYNTHESIS AND BIOTIN-LABELLED cRNA
SYNTHESIS FOR HYBRIDIZATION TO AFFYMETRIX GENECHIPS ®
(Adapted from Affymetrix Genechip® expression analysis technical manual)
Procedures for first-strand cDNA synthesis (one-cycle)




Diluted poly-A RNA controls 2 ul
T7-Oligo(dT) Primer 50 μM 2 ul
RNase-free Water Variable
Total Volume 11 ul
Incubate the reaction in the thermal cycler according to the following program:
70°C 10 minutes
4°C 2 minutes
(Perform all incubations steps in thermal cycler.)
2. In a separate tube, assemble the First-Strand Master Mix as follows:
Starting material Volume
5X 1st Strand Reaction Mix 4 ul
DTT 0.1M 2 ul
dNTP 10 mM 1 ul
Total Volume 7 ul
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3. Transfer 7 ul of First-Strand Master Mix to each RNA/T7-Oligo(dT) Primer mix
for a final volume of 18 ul. Mix thoroughly by flicking the tube a few times.
Centrifuge briefly (5 seconds) to collect the reaction at the bottom of the tube, and
immediately place the tubes at 42°C.
4. Incubate for 2 minutes at 42°C in the thermal cycler. Add 2 ul of SuperScript II to
each RNA sample for a final volume of 20 ul.
5. Incubate for 1 hour at 42°C; then cool the sample for at least 2 minutes at 4°C .
Procedures for second-strand cDNA synthesis (one-cycle)
1. Add 130 ul of Second-Strand Master Mix to each first-strand synthesis sample for a
total volume of 150 ul.
Preparation of Second-Strand Master Mixonent Volume
Starting material Volume
RNase-free Water 91 ul
5X 2nd Strand Reaction Mix 30 ul
dNTP 10 mM 3 ul
E. coli DNA ligase 1 ul
E. coli DNA Polymerase I 4 ul
RNase H 1 ul
Total Volume 130 ul
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2. Incubate for 2 hours at 16°C.
3. Add 2 ul of T4 DNA Polymerase to each sample and incubate for 5 minutes at
16°C.
4. After incubation with T4 DNA Polymerase add 10 ul of EDTA, 0.5M and proceed
immediately to Cleanup of Double-Stranded cDNA
Procedures for cleanup of double-stranded cDNA
1. Add 600 ul of cDNA Binding Buffer to the double-stranded cDNA synthesis
preparation. Mix by vortexing for 3 seconds.
2. Apply 500 ul of the sample to the cDNA Cleanup Spin Column sitting in a 2 mL
Collection Tube (supplied), and centrifuge for 1 minute at ≥ 8,000 x g (≥ 10,000 rpm).
Discard flow-through.
3. Reload the spin column with the remaining mixture and centrifuge as above.
Discard flow-through and Collection Tube.
4. Transfer spin column into a new 2 mL Collection Tube (supplied). Pipette 750 ul of
the cDNA Wash Buffer onto the spin column. Centrifuge for 1 minute at ≥ 8,000 x g
(≥ 10,000 rpm). Discard flow-through.
5. Open the cap of the spin column and centrifuge for 5 minutes at maximum speed (≤
25,000 x g). Discard flow-through and Collection Tube.
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6. Transfer spin column into a 1.5 mL Collection Tube, and pipette 14 ul of cDNA
Elution Buffer directly onto the spin column membrane. Incubate for 1 minute at
room temperature and centrifuge 1 minute at maximum speed (≤ 25,000 x g) to elute.
Procedures for synthesis of biotin-labelled cRNA
1. Add the following reaction components in the order as indicated in the below table.
Starting material Volume
Template cDNA 6ul
RNase-free Water 14 ul
10X IVT Labelling Buffer 4 μL
IVT Labelling NTP Mix 12 μL
IVT Labelling Enzyme Mix 4 μL
Total Volume 40 μL
2. Incubate at 37°C for 16 hours (perform overnight).
Procedures for the clean-up of biotin-labelled cRNA
1. Add 50 ul of RNase-free Water to the IVT reaction and vortex for 3 seconds.
2. Add 350 ul IVT cRNA Binding Buffer to the sample and vortex for 3 seconds.
3. Add 250 ul ethanol (96-100%) to the lysate, and mix well by pipetting. Do not
centrifuge.
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4. Apply sample (700 ul) to the IVT cRNA Cleanup Spin Column sitting in a 2 mL
Collection Tube. Centrifuge for 15 seconds at ≥ 8,000 x g (≥ 10,000 rpm). Discard
flow-through and Collection Tube.
5. Transfer the spin column into a new 2 mL Collection Tube. Pipette 500 ul IVT
cRNA Wash Buffer onto the spin column. Centrifuge for 15 seconds at ≥ 8,000 x g (≥
10,000 rpm). Discard flow-through.
6. Pipet 500 ul 80% (v/v) ethanol onto the spin column and centrifuge for 15 seconds
at ≥ 8,000 x g (≥ 10,000 rpm). Discard flow-through.
7. Open the cap of the spin column and centrifuge for 5 minutes at maximum speed (≤
25,000 x g). Discard flow-through and Collection Tube.
8. Transfer spin column into a new 1.5 mL Collection Tube (supplied), and pipette 13
ul of RNase-free Water directly onto the spin column membrane. Ensure that the
water is dispensed directly onto the membrane. Centrifuge 1 minute at maximum
speed (≤ 25,000 x g) to elute. The average volume of eluate is 11 ul from 13 ul
RNase-free Water.
9. Use spectrophotometric analysis to determine the cRNA yield. Calculate the
adjusted cRNA yield as follows: Adjusted cRNA yield = RNAm - (total RNAi) (y)
RNAm = amount of cRNA measured after IVT (μg)
total RNAi = starting amount of total RNA (μg)
y = fraction of cDNA reaction used in IVT
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Procedures for the fragmentation of cRNA
1. Prepare the fragmentation reaction mix as follows: /64 Format 100 Format
Starting material Volume
cRNA 20 μg (1 to 21 μL)
5X Fragmentation Buffer 8 μL
RNase-free Water (variable) to 40 μL
Total Volume 40 μL
2. Incubate at 94°C for 35 minutes. Put on ice following the
incubation.
3. Store undiluted, fragmented sample cRNA at –70°C until ready to perform the
hybridization to genechip arrays.
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APPENDIX 4.1
DAILY FOOD INTAKE (GRAMS) OVER A SEVEN-DAY PERIOD
CTest Group denotes the group of mice receiving the Control C diet
HTest Group denotes the group of mice receiving the High-fat, calorie-dense (HFC)
diet
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
CTest0 3.13 2.92 3.04 3.06 3.18 3.15 3.12
CTest1 2.94 3.05 3.03 3.10 3.11 2.97 3.17
CTest2 2.96 2.93 2.92 3.18 3.10 2.97 2.96
CTest3 2.90 3.08 3.08 3.11 3.16 3.14 3.04
CTest4 3.14 3.18 2.97 2.95 2.90 3.18 3.12
CTest5 3.17 2.93 3.04 3.14 2.90 3.10 3.17
CTest6 3.11 3.11 3.13 3.08 2.95 3.11 3.16
CTest7 3.16 3.01 2.96 3.06 3.04 3.01 3.04
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
HTest0 3.27 3.21 3.24 3.28 3.39 3.28 3.39
HTest1 3.32 3.22 3.28 3.23 3.24 3.22 3.35
HTest2 3.24 3.30 3.30 3.39 3.29 3.21 3.26
HTest3 3.24 3.34 3.37 3.20 3.20 3.32 3.36
HTest4 3.28 3.36 3.20 3.35 3.33 3.37 3.22
HTest5 3.36 3.37 3.32 3.21 3.37 3.36 3.20
HTest6 3.34 3.26 3.24 3.39 3.39 3.24 3.24
HTest7 3.32 3.39 3.38 3.21 3.37 3.24 3.23
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APPENDIX 4.2
EXAMPLES OF MELTING CURVE ANALYSIS FOR RT-PCR
EXPERIMENTS
An example showing the melting curve analysis of B-actin
An example showing the melting curve analysis of Hmgcr
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An example showing the melting curve analysis of Cpt1L
An example showing the melting curve analysis of Cyp7a1
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An example showing the melting curve analysis of Fasn
An example showing the melting curve analysis of Pparα
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An example showing the melting curve analysis of leptin
An example showing the melting curve analysis of leptin receptor
206
APPENDIX 4.3
AGAROSE GEL ELECTROPHORESIS OF
AMPLIFIED RT-PCR PRODUCTS
Marker 1 2 3 4 5 6
Lanes:
1: B-actin (241bp)
2: Carnitine palmitoyltransferase 1A, liver (173 bp)
3: Peroxisome proliferator activated receptor alpha (126 bp)
4: 3-hydroxy-3-methylglutaryl-coenzyme a reductase (101 bp)
5: Fatty acid synthase (212 bp)
6: Cytochrome P450, family 7, subfamily a, polypeptide 1 (168 bp)
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APPENDIX 4.3 (continued)
AGAROSE GEL ELECTROPHORESIS OF
AMPLIFIED RT-PCR PRODUCTS
Marker 1 2 3
Lanes:
1: B-actin (241bp)
2: Leptin (416 bp)
3: Leptin receptor (373 bp)
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APPENDIX 4.5
WESTERN BLOTS OF HMGCR, FASN AND CPT1L IN THE LIVERS FROM
CONTROL MICE (ODD-NUMBERED LANES) AND
HFC MICE (EVEN-NUMBERED LANES)
HMGCR
Week 2
Marker 1 2 3 4 5 6 7 8
HMGCR
Week 4




Marker 1 2 3 4 5 6 7 8
FASN
Week 2
Marker 1 2 3 4 5 6 7 8
FASN
Week 4




Marker 1 2 3 4 5 6 7 8
CPT1L
Week 2
Marker 1 2 3 4 5 6 7 8
CPT1L
Week 4




Marker 1 2 3 4 5 6 7 8
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APPENDIX 4.6 REFERENCE VALUES FOR PLASMA LIPIDS, GLUCOSE,
LEPTIN AND INSULIN LEVELS FOR FEMALE C57BL/6J MICE
Reference values are compared with the data obtained from our control 2-week mice
(aged 10 weeks) as follows:
Normal values Control mice
(C-2wk)
Plasma glucose (mmol/L) 12.4 + 1.5 15.7 + 3.4
Plasma total cholesterol (mmol/L) 1.9 + 0.4 1.7 + 0.1
Plasma HDL cholesterol (mmol/L) 0.9 + 0.4 1.4 + 0.2
Plasma triglycerides (mmol/L) 0.8 + 0.3 0.8 + 0.1
*Plasma leptin (ng/ml) 2.3 + 1.1 1.4 + 0.3
*Plasma insulin (ng/ml) 0.4 + 0.1 0.3 + 0.1
Values are expressed as Means + SD. All reference values are obtained from Jackson
Laboratory Website http://jaxmice.jax.org, unless indicated otherwise.
* Values are obtained from Murphy et al (1997)
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APPENDIX 5.1
WESTERN BLOTS OF HMGCR AND FASN IN THE LIVERS FROM
CONTROL MICE (ODD-NUMBERED LANES) AND
HIGH-FIBER MICE (EVEN-NUMBERED LANES)
FASN
Week 3
Marker 1 2 3 4 5 6 7 8
FASN
Week 10




Marker 1 2 3 4 5 6 7 8
HMGCR
Week 10
Marker 1 2 3 4 5 6 7 8
